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ABSTRACT

Lee, Steven T. Ph.D., Purdue University, May 2015. Wireless Tools for Neuromodulation.
Major Professor: Pedro Irazoqui.
Epilepsy is a spectrum of diseases characterized by recurrent seizures. It is estimated that
50 million individuals worldwide are affected and 30% of cases are medically refractory
or drug resistant. Vagus nerve stimulation (VNS) and deep brain stimulation (DBS) are
the only FDA approved device based therapies. Neither therapy offers complete seizure
freedom in a majority of users. Novel methodologies are needed to better understand
mechanisms and chronic nature of epilepsy. Most tools for neuromodulation in rodents
are tethered. The few wireless devices use batteries or are inductively powered. The
tether restricts movement, limits behavioral tests, and increases the risk of infection.
Batteries are large and heavy with a limited lifetime. Inductive powering suffers from
rapid efficiency drops due to alignment mismatches and increased distances. Miniature
wireless tools that offer behavioral freedom, data acquisition, and stimulation are needed.
This dissertation presents a platform of electrical, optical and radiofrequency (RF)
technologies for device based neuromodulation. The platform can be configured with
features including: two channels differential recording, one channel electrical stimulation,
and one channel optical stimulation. Typical device operation consumes less than 4 mW.
The analog front end has a bandwidth of 0.7 Hz – 1 kHz and a gain of 60 dB, and the

xx
constant current driver provides biphasic electrical stimulation. For use with optogenetics,
the deep brain optical stimulation module provides 27 mW/mm2 of blue light (473 nm)
with 21.01 mA. Pairing of stimulating and recording technologies allows closed-loop
operation. A wireless powering cage is designed using the resonantly coupled filter
energy transfer (RCFET) methodology. RF energy is coupled through magnetic
resonance. The cage has a PTE ranging from 1.8-6.28% for a volume of 11 x 11 x 11 in3.
This is sufficient to chronically house subjects. The technologies are validated through
various in vivo preparations. The tools are designed to study epilepsy, SUDEP, and
urinary incontinence but can be configured for other studies. The broad application of
these technologies can enable the scientific community to better study chronic diseases
and closed-loop therapies.
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CHAPTER 1. INTRODUCTION

The brain is exquisite, dynamic and complex. The hundreds of billions of
neurons and glial cells coordinate and control our behavior. Since the classic experiments
of Berger, Hodgkin and Huxley (1-5), and Benabid (6), the neuroscience research
community has been in constant pursuit of better tools to study the spatial, temporal,
electrical, and chemical attributes of normal and pathological neural systems. As a
zealous proponent of systematic deconstruction of the central nervous system, Francis
Crick wrote (7):
A major first step, then, is to identify the many different types of neuron existing in the cerebral
cortex and other parts of the brain. One of the next requirements (as discussed above) is to be able
to turn the firing of one or more types of neuron on and off in the alert animal in a rapid manner.
The ideal signal would be light, probably at an infrared wavelength to allow the light to penetrate
far enough. This seems rather farfetched but it is conceivable that molecular biologists could
engineer a particular cell type to be sensitive to light in this way.

In 2005, Boyden et al., followed with the first optogenetic demonstration of
channelrhodopsin-2 (8). Since then, the neuroscience community has seen a tremendous
push for integrated technologies that can match the physical properties of the brain,
capture the resolution and scale of information being acquired and delivered, correlate
multiple data streams to an event, and avoid the immune response. These technologies
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can enable medical researchers to systematically deconstruct circuits and better
understand the mechanism of neurological diseases. The end objective is to develop costeffective, optimized, personalized treatments. Diseases such as epilepsy are complex,
etiologically non-homogenous, and poorly understood. Epilepsy affects ~1% of the
world’s population (9). Approximately 20-30% of all cases are refractory to medication
and the patients may be viable for surgical procedures including vagus nerve stimulation
(VNS), deep brain stimulation (DBS), and focal brain resection. Temporal lobe epilepsy
(TLE) is the largest category of intractable partial epilepsy with seizures predominantly
initiating in the limbic circuitry. Owing to the success of DBS treatment in Parkinson’s
disease (10-12), DBS has been used in hopes of seizure freedom for severely epileptic
patients (13). Two recent major clinical trials have investigated targeting DBS therapy at
a clinically defined focus (14) or the anterior nucleus of the thalamus (ANT)—a site
within the classical Papez circuit (15). A Cochrane meta-analysis showed that both
strategies were effective at reducing seizure rates, but do not have significant responder
rates (at least 50% seizure reduction) within 3 months of the trial (16). DBS may have
longer working mechanisms and has great promise in neuromodulation. It is clear, though,
that much progress is needed to reach seizure freedom for epileptic patients. Further,
severe epileptic patients are at higher risk for sudden unexpected death in epilepsy
(SUDEP). There are currently no effective treatments. Better tools are needed to enable
the research community. This work presents a platform of wireless technologies for use
in rodents to study epilepsy and SUDEP, but the platform can be extended to other
disorders such as urinary incontinence. Sections 1.5-1.7 briefly overview aspects of
epilepsy, SUDEP, and urinary incontinence. The devices presented in each of the
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remaining chapters are standalone and can be integrated as a technology platform for
chronic animal experiments. Chapter 2 focuses on an implantable closed loop device with
biopotential acquisition and electrical stimulation. Chapter 3 presents published work on
a miniature, deep brain optical stimulator for use in optogenetics, and Chapter 4 details a
three-axis omnidirectional wireless powering system to house rodents.

1.1

Wireless Devices

Major goals in developing wireless neural prostheses involve moving towards
more clinically relevant products, observing chronic behavior, and developing high
throughput experimental protocols. A large portion of current rodent neural prostheses
are based upon wired technologies which are disadvantageous due to the restrictive
environment required by the tether, increased risk of infection from the percutaneous
connector, and impractical implementation of large-group, longitudinal monitoring
protocols. Wireless microsystems obviate the tethered disadvantages and transmit
biopotentials with greater fidelity by measuring and processing the signal close to the
source. Devices should contain circuitry for signal acquisition and conditioning,
stimulation, telemetry, and power management. The ideal device would be miniscule,
dissipate extremely low powers to prevent tissue heating, have noise floors below all
signals of interest, and deliver any number of recording and stimulation channels with
continuous operation. There are two primary modalities in neuromodulation: electrical
stimulation and optical stimulation in optogenetics. Electrical stimulation methods are
clinically approved and have been used for decades. It has consumer confidence and has
been used in several clinical devices. Optogenetic modulation is a younger technology
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that has seen tremendous growth in the last 10 years. Optogenetics allows cell type
specific modulation of neurons through genetic techniques and spatial selectivity of tissue
through optical delivery systems. This is a distinct advantage over electrical stimulation,
which can only create transient electric fields in a given volume of tissue. Recording
technologies have been extensively developed in both academia and industry and are
more widely available to researchers. These devices are used to monitor the time varying
electrical potentials in tissue. Tying the recording and stimulation technologies together
to create closed-loop systems is required to further stimulation strategies. Optimized,
controlled, smart personalized therapy is the next frontier in neuromodulation.
The probe tissue interface is the greatest challenge facing neuroprosthetics (17,18).
High-density microelectrode arrays (MEA) provide high spatial resolution data revealing
valuable insights into seizure (19-21). The most prominent probes currently used in
research are microwire arrays, Michigan electrodes, and the Utah array. The chronic
stability of these interfaces, though, is not robust and signals of interest degrade over time
with large variation (22,23). The insertion of electrodes injures the brain, and a persistent,
dynamic immune response results in poor electrode performance (23-26). Using MEA, it
is currently difficult to achieve stable recordings of a specific neuron over a chronic time
period (22,27). These conditions set serious limitations to experimental protocols.
Current seizure detection algorithms use lower frequency content (< 100 Hz) that is
chronically robust (28-31). Several strategies to stabilize microelectrode recordings are
currently under investigation and include: insertion mechanisms for sub 25 micron
diameter electrodes (32), conductive polymers with tissue friendly chemical and
mechanical properties (33), coating flexible electrodes to be stiff during insertion and
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flexible after (34), and coating electrodes with antiinflammatory nanoparticle agents (35).
There is no clear solution and more studies are needed to overcome the probe-tissue
interface. The current limitations should be carefully considered during design of
experimental procedures and associated devices.
Heating of neurons have led to behavioral changes (36) and temperature rises in
tissue can cause cell injury and death (37). Device heating is proportional to power
dissipation, and the physical transfer of heat to tissue is dependent on the heat source
location, heat sinks, and device-tissue interface. As en example, an LED used for optical
stimulation in optogenetics typically generates a significant amount of heat, and the LED
can be mounted on the skull (38-40) or implanted within the brain (41,42). Heating
should be addressed in both methods; however, the latter strategy demands more
stringent constraints and detailed analysis. The intent of this work is not to advance the
understanding of the device-tissue interface, but careful consideration is given to design
and methods that allow observation of chronic biopotentials and minimize tissue damage.

1.2

Electrical Closed-Loop Deep Brain Stimulation Technologies

Wireless biopotential acquisition requires amplification, signal conditioning,
digitization, and telemetry. In epilepsy and SUDEP, the critical signals of interest are
seizures, the electrocardiogram (ECG), and respiration biomarkers. Acquisition units are
capturing the time and frequency content of the signals for analysis (43-45).
Electroencephalogram is the clinical gold standard. EEG is recorded on the scalp, and the
signal is a summation of all extracellular current sinks and sources under the site of
interest (46). A disadvantage of scalp EEG, though, is the low amplitude, spatial
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resolution, and reduced frequency bandwidth (47). The data is typically low pass filtered
with a cutoff of 100 Hz. With animal models, depth electrodes (intracranial EEG) are
implanted, and the resulting signal reflects the activity of a smaller population of neurons
than the EEG with greater amplitudes, spatial resolution, and bandwidth (46,47). The
cumulative response can be filtered to produce two signals: multiple unit spiking activity
(MUA, highpass 300-500 Hz) and local field potentials (LFPs, lowpass 300-500 Hz) (48).
If the electrode tip is sufficiently close to a neuronal body, single unit activity may be
detected. LFP contributions are mainly derived from synaptic activity (46) and is an
important band in seizure detection. The ECG reflects the electrical potential changes
within the heart and can be measured with several lead configurations. The frequency
content ranges up to 100 Hz. Respiration rate can be measured by a variety of techniques,
but of particular interest to this work is external intercostal electromyography (EIC EMG).
In rats, EIC muscles T2-T5 reflect inspiration activity, and the EMG activity has power in
the 100-624 Hz frequency band (49). As more channels and data are required, an
increased emphasis is placed on power consumption per amplifier data reduction
techniques. To reduce demands on telemetry, feature extraction, such as seizure detection,
has been used to only transmit relevant data information (50,51), which can offer
significant (14:1) power reduction (51). Feature extraction also enables asynchronous
telemetry to only transmit after detection (52). To quantitatively assess integrated circuit
topologies during design, a comparison of algorithms and hardware-associated costs can
be of great value (53-55). The size of small rodents place limits on the scale and
architecture of implantable systems. As a result, the wireless technology specifications
are highly dependent on the intended experimental procedure.
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Integrated circuits (IC) are often used for proof of concept demonstrations in
academia (28,51,56,57). Scaling these analog ICs to large animal experiments is
challenging, as it requires a detailed analysis of the fabrication process to limit variability
and maximize yield. Furthermore, IC fabrication, testing, and distribution are costly. It
should be noted, though, that there are successful product contributions from academia to
the medical research community. After many years, Reid Harrison has commercialized
his biopotential ICs into the 16-64 channel amplifiers offered by InTan Technologies (5861). Additionally, Fan et al. presented a 32 channel full system IC with a 50 kHz
sampling (62), and Szuts et al. successfully designed a 64 channel IC with a 20 kHz
sampling rate (63). While full system ICs will always have the most impressive
specifications, the use of commercial off the shelf components (COTS) in device design
can provide the needed reliability in large-scale animal experiments. Microprocessors are
continually optimized for lower power and smaller applications. Perhaps the greatest
advantage is that the time between iterations for COTS devices is rapid. Currently, two
companies provide fully implantable systems: Millar Telemetry Systems (also known as
Telemetry Research, TR) and Data Sciences International (DSI). TR systems provide up
to two channels of biopotential acquisition with a battery and wireless inductive powering
(64). The product is robust but large for rats often requiring intraabdominal implantation.
Inductive powering provides severe limitations in range and coil alignment. DSI has
smaller telemeters with up to two channels of biopotential measurements, but the battery
life of the devices under operation is limited (65). Both devices lack stimulation circuitry
and cannot be modified by labs for closed-loop protocols. One academic COTS device is
capable of closed-loop DBS experiments; however, the device requires a large battery
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backpack, is not implantable, and consumes 31.8 to 53.4 mA of current (66). Another
COTS device has an impressive number of acquisition channels (up to 16 at 20 kHz
sampling) and could be mated to a stimulator for closed-loop DBS; however, it is
prohibitively large (35 x 35 x 35 mm), non-implantable, and only has 6 hrs of battery life
(67). The power consumption and size are not suitable for chronic, continuous
experiments. Table 1.1 compares the current biopotential acquisition devices. It shows
the range of specifications between IC and COTS design, and demonstrates the lack of
suitable closed-loop devices for use in epilepsy.
Electrical deep brain stimulation (DBS) has been FDA approved for use in
Parkinson’s disease, movement disorders, and recently epilepsy. DBS electrodes can be
implanted in the focus for responsive stimulation or bilaterally at the anterior nucleus of
the thalamus (ANT) for open loop stimulation in Canada and Europe. Neither location
offers complete seizure freedom for all patients (68). Typical output waveforms are high
frequency (130-200 Hz), constant voltage or current, and charge balanced. The charge
balanced biphasic waveform is needed to reverse electrochemical processes occurring at
the electrode site (69). In rodent models, it has been observed that high frequency
stimulation (>100 Hz) reduces neuronal excitability in the focus when compared to low
frequency stimulation (5 Hz) (70). A study evaluating the effectiveness of DBS at the
ANT for suppression of acute seizures observed that 100 Hz stimulation raised the
threshold for pharmacologically induced seizures, while 8 Hz could lead to seizures (71).
Interestingly, low frequency 1 Hz stimulation of the ventral hippocampal commissural
white matter tract was able to reduce seizure rates from nearly 4 seizures a day to less
than 1 in a rodent epilepsy model (72).
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Table 1.1 Current Full System Devices for Rodent Biopotential Recordings
Device

(64)
(TR50BB)

Number of
recording
channels

2

HP cutoff, Hz
LP cutoff, Hz
Bandwidth,
Hz
Sampling
Rate

Not reported
Not reported
Not reported
Up to 2 kHz

(65)
(HD-S21)
1
biopotential,
up to 2
pressure
0.1
145
0.1-145
Not reported

(66)

(67)

(62)

(63)

1

7-8 or 1416

32

64

0.32
80
0.32-80

4-300
3000
4-3000

0.8
7000
0.8-7000

10-100
50-4500
10-4500

200 Hz

20 kHz:
14-16
channels

50 kHz

20 kHz

40 kHz: 78 channels
54-90
2.2 µV

58
10 µV

65
<4 µV

Yes;
analog
None

Yes; analog

Gain, dB20
Input referred
noise
Telemetry

Not reported
Not reported

Not reported

Yes; digital

Yes; digital

60
Not
reported
Yes; digital

Electrical
Stimulation
channels
Device
components
Implantable?
Power
consumption
Powering
Source

None

None

Yes

Yes;
digital
None

COTS

COTS

COTS

COTS

IC

IC

Yes
Not reported

Yes
Not reported

No
31.8-54 mA

Battery

Battery

No
Not
reported
Battery

No
645 mW

Rechargeable
battery;
inductive
powering
4-7

No
Not
reported
Battery

2 months

Not
reported
Neural
interface
board:
37 x 26 x 6
mm

1.5

6

6

35 x 35 x
35 mm

2.2 cm3

Head board:
3.5 x 2.5 cm

Battery Life,
hrs
Size (L x W x
H)

28.5 x 24 x
10.5 mm

5.9 cm

3

13

8

4.44 (not
including
battery
pack)

Battery

Transmitter:
5 x 1.5 x 0.3
cm

MCU
board:
27 x 24 x 6
mm
Weight, g

None

Power and
harness:
22

4.5

5 x 4 x 3 cm
52
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Two chronic DBS studies in two different rodent models of epilepsy actually showed that
stimulation caused an increase in seizures (73,74). The variance in efficacy with respect
to stimulation parameters across rodent studies show that successful DBS is heavily
dependent on the seizure dynamics and location of modulation (75,76). A single set of
stimulation parameters may not be sufficient to provide seizure freedom and
combinatorial treatments may be needed (77). Programmable stimulation parameters are
thus crucial in a DBS device. Importantly, none of the aforementioned rodent studies
used a wireless, rodent implantable stimulator. As epilepsy is a chronic disease and
human DBS patients are not tethered, animal studies should reflect the clinical scenario.
Several wireless DBS devices have been made for rodent research (78-84). While these
devices offer biphasic stimulation (78,80-82,84) and programmable parameters (78,8084), these solutions are not suitable for use in chronic epilepsy experiments due to the
size (78,80,84), range of wireless telemetry (83), requirement of inductive powering
pulses to shape stimulus waveform (82), and limited battery life (78-81,83,84).
Additionally, the previous stimulators were not designed for feedback-based, responsive
stimulation experiments. To the author’s knowledge, there is no implantable wireless
device with the capacity to record biopotentials and stimulate responsively. Such a device
would be of great use to the scientific community, especially in the space of epilepsy for
on-demand treatment of seizures (85). This is a significant engineering challenge as the
size of rodents limits the space for extensive circuitry. The devices in Tables 1.1 and 1.2
are all too large for implantable applications and still do not include complementary
stimulation or recording circuitry. Innovations in miniaturization are required.
Incorporation of such a device with wireless technology could address chronic behavioral
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and disease experiments. Microcontroller (MCU) platforms support the implementation
of closed loop architectures and investigation of a new space of experimental paradigms.
This technology begins a small, but necessary step to close the larger gap between basic
neuroscience research, neural engineering, and ultimate clinical application. Chapter 2 of
this work presents a microcontroller centered implantable biopotential acquisition system
and electrical stimulator. The stimulator is wirelessly programmable, miniature (for use
in rodent experiments), and integrated into a closed-loop platform device. The device is
validated in vivo through acute ECG, EIC EMG, and evoked potential measurements.
Additionally, chronic measurements of ECG, Electrocorticogram (ECoG), and LFP are
demonstrated.
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Table 1.2 Current Full System Devices for Rodent Deep Brain Stimulation
Device
Number of
stimulating
channels

(79)

(82)

(84)

(83)

(78,80)

1

1

1

2

Biphasic
stimulation?
Power Supply,
V
Programmable?

Yes

Yes

Yes

Yes

No

Yes

3

4.65

3

3

3.6

No

Yes; not
wireless

Yes; wireless

Yes;
wireless

Yes; tethered

Stimulation
current, µA
Stimulation
frequency, Hz

50-120

20-100

5V
compliance
Yes;
inductive
powering
rectification
100-500

50-600

200-500

13-1000

0-130

131

131

1-200

2-500

Pulse width
duration, µs
Telemetry

0-80

60

Not
reported;
stimulation
current rise
time is 10
µs
50-250

52

30-1400

No

No

No

Yes;
radio

Electrical
recording
channels
On / Off switch

None

None

None

Yes; inductive
near field
communication
None

0-100% of
period
No

No

Yes;
magnet

Device
components
Implantable?
Power
consumption
Powering
Source
Battery Life

COTS

COTS

Yes;
inductive
powering
COTS

Yes; inductive
near field
communication
COTS

No
Not
reported
Battery

Yes
Not
reported
Battery

Yes
Not reported

7 days

2 months

Yes
Not
reported
Inductive
powering
-

Size (L x W x
H)

28 x 15
x 7 mm

14 x 22 x 6
mm

20 x 38.5 x
13.5 mm

Not
reported
20 mm
diameter,
7.2 mm
thick

Weight, g

6.5

2.5

~13

14-16

1

(81)
2

8 mm
diameter,
30 mm
length
2.1

Battery
3-5 weeks

None

None

Yes;
radio

No

COTS

COTS

No
Not
reported
Battery

Yes
Not reported
Rechargeable
Battery
10 days
33 x 20 x 8
mm

11.5
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1.3

Optical Deep Brain Stimulation Technologies

Optogenetics utilizes molecular tools that possess millisecond temporal resolution,
high fidelity (robust response to each input), high precision (repeatable response), and a
lack of immunogenicity (86). The characterization of channelrhodopsins (ChR1 and
ChR2) from the algae Chlamydomonas reinhardtii has opened a window to genetically
encode, tag, and express the protein in mammalian neurons in vitro (87,88) and in vivo
(89,90). ChR2 functions as a single entity and is a non-selective cationic channel
activated by blue light (87). In a mammalian physiological environment, ChR2 can
effectively elicit action potentials within milliseconds of the light stimulus.
Halorhodophsin (NpHR), a microbial silencer that hyperpolarize neurons through the
pumping of Cl-, has also been introduced into mammalian cells (91-93). Since the
introduction of ChR2 and NpHR, rapid optimization and diversification for specific
neuronal functions have emerged (94-97). The potential to control specific neurons,
determine their anatomical connections, and deem them necessary and/or sufficient for a
particular behavior—physiological or diseased—could have serious implications in our
understanding of the brain.
Optogenetic studies fundamentally rely on the delivery of light to the neurons.
Most optogenetic studies to this point have used ultra high power (UHP) lamps or lasers.
Some have used LEDs. Anatomically, the two main classes of structures of interest are
cortical and deep brain. To reach the targets using an UHP lamp or laser, an optical fiber
can be coupled and implanted stereotactically with or without a guide cannula (98). LEDs
can either be placed against a thinned skull or craniotomy to reach cortical structures.
The LED can also be used similar to a laser or lamp with a coupled fiber (99). For deeper
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brain structures, an optical fiber is typically used due to the limits of light transmission
from scattering of photons in the parenchyma (100). LEDs are advantageous because of
the low power requirements (low forward voltage compared to lasers), long operational
life time, narrow band spectrum (compared to UHP lamps), and lack of extraneous
components (i.e. filters) (101). LEDs can also be pulsed at nanoseconds (102), thereby
easily surpassing the kinetics of opsins. UHP are more advantageous due to their high
density of optical power (103) while lasers provide highly directional and coherent beams
of light and have thus been used in most fiber-coupled applications (41,98,104). Others
have attempted to use two-photon systems to selectively stimulate spatially distinct
regions, and holography (105) with digital mirrors have been tried as well. As wirelessly
powered devices must be inherently energy efficient and lightweight, UHP lamps cannot
be used as a light source. Laser diodes, especially vertical cavity surface emitting lasers
(VCSEL) are attractive; however, the products are sparse in academia and industry. The
LED is ideal because of its low profile and dimensions, low forward voltage, and low
threshold current (106).
The current molecular optogenetic systems have a high variance in performance
due to several confounding factors (low conductance, trafficking, expression levels,
delivery technique), and this makes specifications for optogenetic stimulators (OGS)
ambiguous. It is generally agreed upon, though, that an irradiance of 1 mW/mm2 at the
plane of the targeted neuron is required for minimal activation and 10 mW/mm2 for
maximal activation (λ = 473 nm) (107). The optical spectrum of ChR2 peaks from 460470 nm (87). In attempts to quantify the amount of radiance required from the fiber tip to
activate a given volume of tissue, a Monte Carlo scheme (41,108) and Kubelka Munk
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model (107) from empirical rodent brain slice data have been widely used. According to
the Kubelka Munk model, a 200 µm core diameter fiber (0.37 NA) with 3 mW total
power output (λ = 473 nm) can reach a depth of ~0.8 mm before falling below 1
mW/mm2 (109). Because the models are inexact, in vivo brain tissue properties are
difficult to acquire, and it is unknown how many of a specific neuron type needs to be
recruited for specific behaviors, it may be best to derive the required optical radiance
from empirical studies with behavioral outputs. Due to the variability and many
unknowns, a wide range of programmable stimulation parameters is needed. This would
allow psychometric curves to be determined for a given optogenetic system (110).
An optical stimulator for optogenetics should provide enough optical power for
cortical and deep brain structures and offer programmable stimulation parameters. There
have been a few previously published wireless stimulators that use light emitting diode
(LED) as a light source. The LEDs are either implanted in the brain (42) or mounted on
the skull on top of a cranial window (39,40,111). Programmable stimulation parameters
are critical for consistent optical output, and behavioral modifications require specific
firing patterns (112). Further, exposure at 10 – 100 mW/mm2 (1-10 W/cm2) of optical
irradiance for a 1 second pulse can induce phototoxicity (113,114). In other reports, the
Deisseroth group suggest that stimulating at 75 mW/mm2 for 50 ms pulses is the upper
limit to prevent tissue damage (104). Without optical control, tissue damage could occur.
Two published devices cannot precisely control the optical power emitted (39,42). Deep
brain targeting is essential for epilepsy research. The two closed-loop optogenetic studies
targeted neurons within the thalamus or hippocampus (85,115). This is a challenge as
coupling light from an LED to a 200 µm diameter optical fiber is inherently inefficient.
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While previous devices have claimed the ability for deep brain targeting, demonstration
is lacking (39,40,111). The most promising technology, a custom fabricated flexible and
implantable LED interface, is not widely accessible (42). The miniaturization and design
of a LED-based device with programmable stimulation parameters to better control and
systematically perturb neural circuits in chronic epilepsy animal models is needed.
Chapter 3 presents a microcontroller based deep brain optical stimulator for use in
optogenetics. The most innovative contribution is the coupling technique as it allows the
miniaturization of the optical power source. The device is validated in vivo with mice
performing a conditioned place preference (CPP) behavioral paradigm. It is shown that
conditioned place preference increases in a dose-dependent manner.
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Table 1.3 Current Optical Stimulation Devices for use in Optogenetics
Device
Light Source
Programmable
features

(39)
LED

(40)
CREE chip LED

300 us – 300 ms
(TTL)

(42)
Custom
inorganic LED
Pulse Powering
and passive
rectification
shapes
stimulation
output.

(111)
Multiple LEDs
Infrared telemetry:
Duration of stimulation
(> 1 ms)

No
Yes;
injectible LEDs

Frequency (< 500 Hz)
No
Yes;
Fiber diameter: 0.5 mm
Implant LED:

Fiber?
Deep brain
capability

No
No

Radio Telemetry;
Millisecond
resolution for y
for pulse width,
duration, and
period of
stimulation
No
No

Demonstrated
DBS
Power
consumption
Powering source

No

No

Yes

No

> 60 mW

100s of mW to
>4 W
Inductive
powering

3-40 mW

Not reported

RF scavenging

Rechargeable battery
(10 mAh)

Rectifier board:
~1.2 cm x 1.2
cm

14 mm x 14 mm x 10
mm

Size (L x W x H)

Lithium batteries
Body:
24mm×9mm×9mm;

< 1 cm3 without
supercapacitor

Battery holder:
5mmOD×9mm
Weight
Behavioral
output

3.1 g
Rotations from
motor cortex
stimulation in mice

1.4

2-3 g
Rotations from
motor cortex
stimulation in
mice

Probe:
0.5 mm wide
0.25 mm thick
Not reported
Conditioned
place preference
(CPP) in mice

Pulse width (> 1 ms)

2.4 g
Rotations from motor
cortex stimulation in
mice

Wireless Power Transfer Systems

Wireless power transfer (WPT) has a storied history and has captured the
imagination of researchers since Hertz and Tesla (116). Application of WPT to
implantable devices is an inherent challenge and necessary technology. Powering on
demand eliminates the need for a tether and allows devices to have lifetimes far
exceeding the length of chronic experiments. Radiofrequency (RF) powering is the most
prevalent strategy used since it can safely deliver the power required by devices (see
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Tables 1.1-3). RF powering strategies can be classified into near field, mid-field, and farfield. Power transfer occurs when a source generates alternating magnetic and electrical
fields to induce currents in the receiver. Great attention must be given to requirements of
the application as that dictates the appropriate WPT strategy and system architecture. Full
system biomedical implants for rodents typically consume milliwatts of power, and the
small size of the animals limits the size of the power receiver. As power transfer
efficiencies (PTE) are typically low (< 5%), maintaining the proper impedance match
conditions for optimal power delivery over a wide range of space and antenna
orientations is crucial. Additionally, the WPT system must be safe. The Federal
Communications Commissions limits the radiation and human exposure levels of radio
waves from RF devices (117). Tissue heating and interactions are due to radiation and
electric field components of the electromagnetic waves (118,119). Devices that use
radiated electromagnetic fields as a powering source must be cautious of the exposure
limits (120). One such previous device exceeded the FCC guidelines (42), and end users
should be given proper warning. At frequencies below 10 MHz, the magnetic fields have
little known direct interactions with biological tissues (118,121). WPT systems should
operate below 10 MHz with primarily magnetic induction or have an extensive analysis
showing that the exposure is safe for use (122).
The dominant method in the near field powering is inductive powering. Energy is
coupled through magnetic induction, and this technique is widely used in commercial
applications. Yet with many years of development and optimization, there are few
clinical and research products. The inherent limitation is true omnidirectional powering in
free space. Between the transmit and receive coils there is only a limited operating range
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and coil orientation in which strong induction is achieved (123,124). Transcutaneous
energy transfer systems (TETS) have been proposed for decades (125) and clinically
implemented with little success (124,126,127). Inductive powering has been
implemented in many implantable devices, but the range is typically limited to less than
10 cm for receive coils 6 cm in diameter or less (128-131). The most extensive research
product developed is the Enercage inductive powering platform (132). The Enercage is
an array of overlapping transmit spiral planar coils with multiple controllers to optimize
power transfer to the receive unit. The power transfer efficiency at a 15 cm vertical
distance is approximately 2-3%, and the system can deliver 20 mW to a 500 Ω load at 12
cm (132). While this is an impressive engineering solution, the platform is incredibly
sophisticated; difficult to reproduce; limited in vertical powering range; and has two coils
(40 and 25 mm diameters), a monopole antenna (48 mm) and a large supercapacitor as an
energy buffer on the power receive board (132). Such a powering system is not suitable
for chronic epilepsy experiments.
Mid-field RF powering is a novel technique using both magnetic induction and
electrical radiation (122,133). Potential applications include those where the source and
receiver are approximately a wavelength apart. At this distance, efficiencies are higher
than using inductive near field; however, the current physical setup is rigid to the
optimized distance (122). A major advantage is the miniaturization of the receive coil.
Recently, a ~3 mm diameter receive coil and a custom IC LED driver was implanted in a
freely behaving mouse (134). At a distance of 15 cm and 500 mW output power (1.6
GHz), 50 µW is received when embedded 0.75 cm deep in porcine tissue (134). While
this method is promising, especially for coil miniaturization, it is also confined to a
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limited vertical range and not currently amenable for design. Designers must wait for
simplified mathematical methods and further characterization. The far-field couples
energy through electrical radiation and operates in the 100’s of MHz to low GHz. This
method can power at distances much greater than the wavelength and offers more
freedom with orientation mismatches, but the efficiencies are low (135) and not suitable
or safe for implantable applications requiring milliwatts of power. Tissue penetration is
shallow, and safe exposure levels set a ceiling for radiated power from the source (120).
Strongly coupled magnetic resonance (SCMR) for wireless power transfer is a
non-radiative, mid range powering method (136). Energy is coupled by a resonant
magnetic field, and the physical principles are the same as inductive powering (123). The
primary differences from inductive powering are the use of high quality factor
components and system architectures that allow optimization of the impedance match
condition (123,137,138). These two factors increase the range of power transfer. As
demonstrated by Kurs et al., high power transfer efficiencies can be achieved at distances
several times the diameter of the powering coils (136). Even with large mismatches coils
sizes power transfer efficiencies can reach 9.1% across multiple receivers (138). This
feature is critical as implantable devices necessitate miniaturization. SCMR power
transfer has been quickly adopted and already seen prototypes for clinical use (139,140).
Application of SCMR power transfer to rodent implantable devices, though, has been
lacking. Xu et al. presented a mat-based WPT system similar to the Enercage; however,
this was only realized through simulation for a specific distance as the interactions
between an array of resonant coils is quite complex (141). Table 1.4 compares a selection
of inductive, midfield, and SCMR power methods. A powering system for chronic
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epilepsy experiments would require continuous powering within the volume of a housing
unit. According to the NIH Guide for the Care and Use of Laboratory Animals, group
housing rats weighing 400-500 g require 60 in2/rat of floor space and 7 inches of height.
Often rats induced with seizures are singly housed and would require more floor space.
An 11 x 11 x 11 in3 (L x W x H) volume sufficiently house a large rat with seizures.
None of the solutions in Table 1.4 adequately address this volume with a miniature,
implantable receive coil. Recently, the design of SCMR powering systems has been
greatly simplified through microwave filter synthesis techniques (142-145). By simply
modeling a SCMR WPT system as a bandpass filter, optimal impedance match
conditions for maximum power transfer can be met with simple and miniature circuit
topologies (143,144,146). In particular, the resonantly coupled filter energy transfer
(RCFET) method optimizes power transfer simply through measurement of the physical
coil parameters (147). Using the RCFET method, Chapter 4 of this work presents an
omnidirectional powering cage to support the technologies detailed in chapters 2 and 3.
The powering strategy is designed and characterized with filter synthesis theory and
validated in vivo with freely behaving rats.
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Table 1.4 Wireless Power Transfer Systems
WPT
system
Method
Powering
frequency
Powering
Range

Powering
Area
Source
Coil

Receive
Coil
diameter
Receive
board
size
Power
output
Power
received
Notes

(131)

(130)

(132)

(134)

(141)

(138)

(140)

Inductive

Inductive

Inductive

Midfield

SCMR

SCMR

SCMR

6.78
MHz
1.5 cm

3.18
MHz
4 cm

13.56 MHz

1.6 GHz

8.3 MHz

15 cm

15 cm

26.6
MHz
8 cm

13.56
MHz
< 50%
PTE: 120
cm

17 cm

Not
reported

Not
reported

3538 cm2 or
larger

8 cm
diameter

16 x 16
cm

Not reported

5.2 cm

4.8 cm

unit tile: 515
x 450 mm

25 mm

~3 mm

Seven
13.2 cm
spiral
coils
arranged
in a
hexagon
Diameter:
25 mm

30 cm

can add tiles
to create
larger area

Cross slot
source 5 cm
below a tank:
powers a tank
with 8 cm
diameter

1 cm

0.6 cm

Not
reported

4.5 x 7.5
x 1 mm

259 mW

Not
reported
341 µW

50 mW

40 mm
diameter; 20
mm height
0.5 - 4 W

~3 x 3 mm

20 mW

50 µW

Demonstrated
in vivo with
rats

Demonstrated
in vivo with
mice

500 mW

Height: 7
mm
Inside
receive
coil
Not
reported
1.19 –
1.44 V;
no load
specified

<10%
PTE: 160
cm
Dependent
on Tx coil
size
Source
coil: 31
cm
Relay coil:
59 cm

1.3 cm

9.5 cm

Not reported

Not
reported

~310 mW

8.1 W

3.3 mW

~4.5 W

Powered
LEDs in
demonstration

Can use
relay coils
to extend
range.
Powering
distance
and area
are coil
size
dependent.
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1.5

Epilepsy

It is estimated that over 50 million individuals across the globe suffer from
epilepsy (9). Epidemiological studies reveal that 20-30% of patients suffer from
refractory or drug-resistant seizures (148). As defined by the ILAE, epilepsy is “a
condition characterized by recurrent (two or more) epileptic seizures, unprovoked by any
immediate identified cause” (149). Importantly, the pathological state can cause severe
insults in cognitive development, autonomic function, and motor control, which lead to a
dramatic decrease in the quality of life and possibly death. Often, drug-resistant
individuals will develop anxiety, depression, and other psychiatric disorders (148).
Furthermore, epilepsy can be socially polarizing. Strong stigmas exist in certain cultures
which lead to under diagnosis of the condition in surveillance studies and negative
societal attitudes towards those affected (150). The CURE Epilepsy foundation estimates
the United States spends approximately $15.5 billion annually and the cost will continue
to rise, especially with soldiers returning from overseas conflicts with traumatic brain
injury (151). With the profound personal, social, and economic burden of epilepsy, new
tools are under development to better understand and treat the disease.
Since epilepsy is a complex and diverse disease, it is important to characterize
seizures carefully. As described by the ILAE, epileptic seizures are categorized into two
distinct types: generalized and partial (149). Generalized seizures are thought to affect the
entire brain from the onset. Partial seizures are believed to manifest from a local focus,
recruit other neurons, and can possibly generalize. Partial seizures are further classified
into simple and complex. Individuals with simple seizures do not lose consciousness
while those with complex do. The etiologies of epilepsy are idiopathic (mainly genetic),

24
generalized (identifiable prior insult), and cryptogenic (unknown) and the temporal
progression towards epilepsy is known as epileptogensis (152). Interventional strategies
may be dependent on the stage of epileptogensis (Figure 1.1).

Figure 1.1 Epileptogenesis. A normal brain undergoes a genetic, known, or unknown
insult and develops into an epileptic brain. Interictal spikes are seen on EEG and
normally do not progress to seizures. If underlying triggering factors are present, neurons
begin recruitment and seizures result. The ictal wavefront propagates at speeds of 13-85
mm/s in cortical rat slices (153) and 0.12 – 0.26 mm/s in human cortical tissue (21).

Current therapies in drug-resistant epilepsy are surgical resections or lesions, ketogenic
diet, the vagal nerve stimulator, and deep brain stimulation. Trigeminal nerve stimulation
(TNS) is currently under investigation in the United States. The responder rates of the
devices for a ≥50% reduction in seizures are widely variable, and most patients do not
become seizure free (154,155). Closed-loop stimulation is an old concept, though, only
recently has a product been under clinical investigation (156). Responsive stimulation
aims to prevent the spread of seizures (Figure 1.1) before it recruits more neurons.
Closed-loop stimulation may be more advantageous from a biological perspective as
neurons can be hyper-stimulated into a refractory state termed stimulation-induced
depression of neuronal excitation (SIDNE) (157). Additionally, from a device perspective,
by stimulating only when required, battery-life of devices can be extended. In
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NeuroPace’s RNS clinical trial, only 46% of the patients met the 50% reduction
responder rate (156). These results do not out perform previous open loop strategies. The
reasons are unclear, but recent studies have shown promise. While all of the
aforementioned treatments are beneficial to many patients, it is clear that new and
optimized treatments are needed for complete seizure freedom. Two landmark studies
using optogenetics demonstrated seizures could be stopped immediately upon detection
with optical stimulation (85,115). Translating and optimizing the molecular and electrical
based closed-loop strategies into clinical efficacy will require device-based tools for
chronic neuromodulation. Chapters 2-4 present a platform of technologies developed
specifically for chronic neuromodulation in rodent epilepsy models.

1.6

Sudden Unexpected Death in Epilepsy

Sudden unexpected death in epilepsy (SUDEP) is a category of death afflicting
patients with epilepsy. Persons with epilepsy are greater than 20 times more likely to die
unexpectedly than the general population (158), and refractory epilepsy patients are at
even greater risks. By definition, definite SUDEP meets the following criteria (159): 1)
sudden 2) unexpected 3) witnessed or unwitnessed 4) if witnessed, no non-epilepsy
related identifiable cause such as drowning 5) seizure or no seizure observed 6) if a
seizure is observed, it cannot be status epilepticus (seizure duration ≥ 30 minutes) 7) no
causal evidence of death during autopsy. The mechanisms of SUDEP are poorly
understood but are thought to include seizure related cardiac and respiratory arrest, and
severe dysfunction of autonomic regulation through limbic, sympathetic, and
parasympathetic pathways (160-162). Nei et al., observed cardiac repolarization
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abnormalities and that the heart rate increased more in SUDEP patients (149 beats/min)
when compared to intractable epilepsy patients (126 beats/min) during the ictal period of
a seizure (163). Cardiac arrhythmias are common in intractable epilepsy patients as well
(164), and pinpointing what leads to SUDEP will require further studies. A Lack of
respiratory drive due to seizures leads to postictal apnea, which then causes hypoxia,
hypoxemia, and acidosis (162,165,166). A dysfunctional cardiorespiratory feedback
system can prevent recovery and result in death (165). In a study with audiogenic
seizures, on oxygen rich environment provided after a seizure was able to prevent
postictal sudden death (166). Known risk factors include: poorly controlled seizures,
using several antiepileptic drugs (AED) with little therapeutic effect, 3-12 generalized
tonic clonic seizures (GTCS) per year, frequent long seizures, and young males (160).
Additionally, those with genetic susceptibility to cardiac arrhythmias are more likely to
experience SUDEP (167). Currently, there are no effective prevention measures.
Physicians can identify those most at risk and offer precautions (161). The vagus nerve
stimulator (VNS) could prevent cardiac instability but this is still unclear (168). It has
been observed that SUDEP often occurs during sleep at night (163,169), so tools for
continuous monitoring are needed. To provide more efficacious prevention and treatment
measures, a better understanding of SUDEP is required. A key challenge is to relate
epileptogenesis and seizure activity in specific brain regions with cardiac and respiratory
signals in animal models. Autonomic regulation can be studied by observing heart rate
variability with respect to other physiological measures such as breathing and blood
pressure (170,171). As SUDEP is currently unpredictable, chronic monitoring is needed
to observe the trajectory of the pathology. Animal models are needed that reflect the
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human phenotypes and mechanisms. Critically, miniature wireless technology provides
an essential toolset for SUDEP researchers. Chapter 2 demonstrates a recording platform
that allows 4 channels of biopotential acquisition to observe a combination of ECoG, LFP,
respiratory EMG and ECG activity.

1.7

Urinary Urge Incontinence

Urinary incontinence (UI) is the inability to control the mictruition. Greater than 25%
of women (172) and greater than 11% of men (173) 60 or older report UI. UI is divided
into stress incontinence (external urethral sphincter dysreguation) and urge incontinence
(bladder control dysregulation). Urge incontinence is typically more severe and requires
medical treatment. The etiologies are wide ranging from aging to neurological disorders,
and the symptom can cause great physical, psychological, and social discomfort. Central
nervous system control of bladder function is regulated through the periaqueductal grey
(PAG). The PAG is under tonic GABAergic inhibition, and when the bladder is full,
stretch receptors in the bladder send ascending signals through the spinal cord to the
midbrain. The PAG is disinhibited, and an efferent voiding signal is sent back down to
the bladder for mictruition. Previously, it has been established that deep brain stimulation
of the PAG in both rats and humans can prevent voiding in a full bladder (174). This has
large implications for patients with urge incontinence, but before human clinic trials can
begin, chronic device based animal studies should be pursued. Closed-loop technologies
can be used to measure the bladder pressure and stimulate the PAG accordingly to offer
control over the urge to void. Chapter 2 details a pressure sensing device prototype and
validates the technology in an acute in vivo bladder pressure experiment.
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CHAPTER 2. BUILDING BLOCKS FOR A CLOSED LOOP SYSTEM

2.1

Introduction

Wireless closed-loop devices for epilepsy are designed to gather and input information
responsively with minimal to no side effects. The system architecture determines the
functional capabilities, and seamless integration of hardware blocks is necessary for
robust full system performance. The key hardware blocks include the physical probes,
analog front-end acquisition (AFE), analog-to-digital converter (ADC), stimulation
circuit (electrical or optical), telemetry, and power management (Figure 2.1)
Biocompatible, metal electrodes will be used to acquire information from a subject, and
the electrode tissue interface must be considered during design of the input analog front
end (AFE) (175). Delivering information or a stimulus can occur electrically or optically
with electrodes or LEDs, respectively. Control of the stimulation parameters is critical. It
is well known that specific stimulation protocols can provide relief in Parkinson’s disease
(176), affect behavior (112), and selectively activate neurons (177). End users must have
a simple way to communicate to the device, and this is executed through a graphical user
interface (GUI) and basestation. While less glamorous in the research realm, seamless
operation of the GUI and basestation is required for adoption by external end users.
Wireless powering for continuous powering is an active area of research and will be
discussed in chapter 4.
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Figure 2.1 Closed-loop system blocks for complete wireless operation. Red arrows show
the path of information delivery to the user. Green arrows show the path of user
controllability and blue arrows show the delivery of information to the subject. Black
arrows show the powering path. The dotted line outlines the physical components on the
device.
A designer must always consider how all blocks of the system interact. This chapter will
specifically focus on the device platform and the design considerations. The GUI and
basestation are contributions of other individuals and will not be discussed. Section 2.2
provides a brief overview of the device for closed-loop modulation. The device has 1
channel for biopotential acquisition and 1 for channel stimulation. Sections 2.3 and 2.4
detail the biopotential acquisition and stimulator design, respectively. Section 2.5 briefly
describes the MCU operation and telemetry. Section 2.6 details the in vivo validation of
ECG, EMG, ECoG and LFP. Section 2.7 then applies the platform for pressure
monitoring in urinary incontinence. The novel intellectual contributions to this work are:
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1)

The design and characterization of a miniature, implantable closed-loop
device for biopotential acquisiton and electrical stimulation

2)

In vivo application of the wireless platform in preliminary studies of SUDEP
and urinary urge incontinence.

2.2

A Miniature Closed-Loop Device for Neuromodulation

The device platform consist of subsystems to detect and amplify biological
signals, input a stimulus, communicate through telemetry, make logical decisions, and
receive power. This section presents a miniature closed-loop device with 1 channel of
biopotential acquisition and 1 channel electrical stimulation. The device block diagram is
depicted in Figure 2.2a. The analog front end (AFE) signal chain consists an
instrumentation amplifier (INA) cascaded with an operational amplifier (OPA). An 8-10
bit analog to digital converter (ADC) internal to the microcontroller (MCU) digitizes the
amplified biopotential. The MCU packages the data for telemetry through an onboard
radio at 2.4 GHz. The constant current stimulator consists of a current sink topology with
dual pole, dual throw switches at the output to flip the polarity of delivered current. The
miniature device is pictured in Figure 2.2b,c with the AFE on the top side and the
stimulator circuitry on the bottom side. The device is 7 x 14 x 3 mm (L x W x H) and
weighs less than 0.7 g (powering circuitry not included). Detailed descriptions of the
circuit topologies are provided in Sections 2.3-2.5. As commercial off the shelf (COTS)
components are used for fast iterations and widespread accessibility, the internal
structures of the electrical systems are not focused upon. Instead, emphasis is placed on
functional performance and design tradeoffs. The building blocks presented are the first
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generation technologies for this platform. The individual subsystems used for acquisition
and stimulation can be combined to design devices at a small size for specific
experiments. For instance, a 4 channel recording system is used in Section 2.7 for
preliminary experiments to study SUDEP. 1 channel stimulation device can be combined
with biopotential acquisition blocks for closed-loop protocols.

Figure 2.2 A miniature closed-loop device with 1 channel of biopotential
acquisition and 1 channel electrical stimulation. a) Block diagram of the device.
Electrodes 1a and 1b are the probes to connect the tissue to device. Two stages of
amplification are performed. The first stage is an instrumentation amplifier (INA) and the
second stage is an operational amplifier (OPA). Digitization of the analog signal is
performed by the internal analog to digital converter (ADC) of the microcontroller
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(MCU). The MCU also has a radio for two way communications with the basestation (not
shown). The constant current stimulator is a standard current sink with switches to flip
the polarity of stimulation. Electrodes 2a and 2b deliver the current to the tissue. For
detailed circuit diagrams of the analog front end (AFE) and stimulator see Figure 3.3 and
3.5, respectively. b) The top side of the device contains the AFE circuitry. The device is
pictured with flexible cuff electrodes used in peripheral nerve modulation. XTAL is the
crystal for the MCU. Refer to block diagram for connections. c) The bottom side of the
device contains the stimulation circuitry.
2.3

Biopotential Acquisition - Analog Front End

Biopotentials can be found anywhere a time varying electric dipole exists. While
the electroencephalogram (EEG) is the gold standard in the clinical workup of epilepsy
and other neural disorders, researchers are also interested: action potentials, local field
potentials (LFP), electrocorticograms (ECoG), electrocardiograms (ECG), and
electromyograms (EMG). The frequency and voltage amplitude content of these signals
are depicted in Figure 2.3 (58,178). Current rodent studies in epilepsy primarily use EEG
and LFP signals for analysis, and the frequency content is below 200 Hz. The ECG
frequency content is within this bandwidth, but higher frequency EMG activity can be
observed. The electrodes being used determine the detectable EMG bandwidth. Typical
surface EMG is limited to 500 Hz activity, while fine intramuscular probes can detect
motor unit action potentials with frequencies over 1 kHz (179). As this work is focused
on using EMG measurements to determine respiration rates (49), motor units do not need
to be observed. To satisfy the bandwidth required to observe electrographic seizures,
ECG, and EMG activity, the low pass filter is designed for 1 kHz. If higher frequency
signals are of interest to a particular experiment, the low pass filter can be reconfigured.
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Figure 2.3 Frequency content and amplitudes of common biopotentials.

In a typical signal chain, each set of electrodes interfaces with a differential amplification
scheme. After the first stage of amplification, often termed preamplification, the signal is
high pass filtered to remove any slow potentials or DC offsets. A second stage of
amplification is used for increased gain, and the low pass filter prevents aliasing. The
resulting signal is digitized and transmitted. The signal chain from electrode output
(amplifier input) to digitization is termed the analog front end (AFE). The purpose of the
AFE is to differentiate the signal from noise; it must have the ability to measure a specific
electrical marker that correlates to a physiologically relevant event. Figure 2.4 shows a
typical signal chain and how the device accomplishes the features.
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Figure 2.4 AFE features. (Top) Typical features in a generic amplifier chain. (Bottom)
The AFE specific to the closed-loop device. An input filter limits radiofrequency
interference and an instrumentation amplifier (INA) is the first gain stage. A high pass
filter removes DC offsets and then an operational amplifier (OPA) serves as both the
second stage of amplification and anti-aliasing low pass filter. The ADC in the MCU
digitizes the amplified signal.

To maintain signal fidelity, additional important design features of the AFE are listed in
Table 2.1. A detailed circuit schematic is provided in Figure 2.5. This schematic will be
used to explain features and design choices. The AFE uses a cascaded amplifier topology
with input and output filters (Figure 2.4-5). The electrode inputs are configured
differentially and connected to an INA. Input filters between the electrodes and INA are
used and component values are carefully implemented to minimize conversion of
common mode to differential signals. The INA rejects common mode noise and provides
preamplification. The second stage amplifier provides further amplification and signal
conditioning. The topology only requires 2 physical connections to the subject and is
considered ground free—no ground electrode is connected to the subject (180). This can
prevent current discharge into the subject under device fault conditions and ease the
surgical procedure.
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Table 2.1 Analog Front End Design Specifications
Design Parameter
Input impedance

Specification
Hundreds MΩs - GΩs

CMRR

80 dB

Low input-referred noise
Gain

< 10 µV
60 dB (1000:1)

Input dynamic range

35.56 dB

Size
Power consumption

<5 x 10 mm2
< 280 µW/mm2

Reason
To prevent voltage division
and observe activity at point of
electrode. Exact impedance
needed depends on electrodes
used.
Rejection noise, primarily
from main power lines (50 or
60 Hz)
To observe small signals
Amplify and increase
resolution
Measure wide range of signal
amplitudes (20 µV-1.2 mV)
Miniaturization
Prevent heating of biological
tissue. Minimize as much as
possible to lessen powering
demands

Figure 2.5 Circuit Topology of Analog Front End. INA = instrumentation amplifier, OPA
= operational amplifier, MCU = microcontroller, ADC = analog to digital converter,
DAC = digital to analog converter, R = resistor, C = capacitor.
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2.3.1

Input Impedance

Input impedance of the INA is ideally infinite to prevent voltage division with the
electrode. There are two input impedances, the differential, Zdm, and common mode, Zcm.
The differential impedance must be large to maintain signal integrity, and the common
mode impedance should be sized to minimize noise. The reported input impedance,
typically differential, of most clinical amplifiers used in epilepsy centers is 10-50 MΩs
(181). Electrode impedance is frequency dependent, changes over time, and variable
between electrodes. From 1 Hz and 2 kHz, microelectrode impedances can range from a
few MΩs to 10 kΩs, respectively (182). Geddes et al. reported that faithful EMG
recordings could be acquired with input impedances ranging from 1 to 88 MΩ for
stainless steel electrodes having areas of 500 to 125000 µm2 (183). More recently, it was
suggested that at least a 1 GΩ input impedance is required to prevent signal distortion of
lower frequency content when microelectrodes are used in the clinic (181). Achieving a
1 GΩ input impedance with limited space is not always practical, though. For instance,
the state-of-the-art Intan Technologies RHD2000 chip has a 13 MΩ input impedance at 1
kHz. Unfortunately, commercial devices from Telemetry Research and DSI do not report
the input impedance specification. In Figure 2.5, the INA used is the INA333 since it has
a differential input impedance of 100 GΩ (184). The common mode impedance, though,
is determined by input biasing resistors, R3 and R4, and filtering capacitors, C1 and C2.
Here, the discussion will be focused on the resistor values as the capacitors are set to 100
pF to minimize RF interference (Section 2.3.4). The resistors are required to center the
input signal, and since Zdm is essentially infinite compared to Zcm, common mode signals
see R3 and R4 as an impedance divider network with the electrode impedance (185). If R3
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and R4 are not large with respect to the electrode impedance, then mismatches in
electrode impedances will result in larger contributions from common mode to
differential signal conversion (potential divider effect, Section 2.3.3) (186). This will
degrade the signal quality by introducing noise. In this work, 10 MΩ bias resistors with a
1% tolerance were chosen since the power line noise contribution is simulated to be a few
µVs with a CMRR of 80 dB (Section 2.3.3). Novel topologies should be investigated to
further decrease noise contributions in low power, two-electrode topologies.

2.3.2

Common Mode Rejection Ratio and Differential Gain

The common mode rejection ratio (CMRR) is the ratio of differential gain, Ad, to
common gain, Acm (equations 2.1-3). A high CMRR amplifies differential signals while
minimizing common mode signals. Impedance mismatches in the internal circuitry cause
common mode signals to appear differential, and this will lower the CMRR. External
components at the input of the INA (R1-4 and C1-2) can also severely degrade CMRR;
this is known as the potential divider effect. To demonstrate, a 10 pF capacitance is added
to C2, which creates a 10% mismatch between C1 and C2 (Figure 2.5). Figure 2.6 shows
a greater than 20 dB decrease in CMRR due to the 10 pF mismatch (red trace). The
potential divider effect does not reduce the differential gain (Figure 2.7), so it is
important to measure the common mode gain to detect CMRR degradation. By selecting
well-matched (within 1%, NP0 temperature rating) input resistors and capacitors, a
CMRR of 100 dB at 60 Hz is achieved (blue trace, Figure 2.6). The CMRR is measured
using a dynamic signal analyzer. First, the differential gain is measured by applying a
differential mode voltage source. Then the common mode gain is measured by applying a
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common mode voltage source (input terminals connected together). The gain is the ratio
of Vout over Vin. Vin is either the differential input voltage, Vdm, or the common mode
input voltage, Vcm (Equations 2.1-2.2). CMRR is obtained with Equation 2.3.

Ad =

€

€

Vdm
Vout

(2.1)

Vcm
Vout

(2.2)

Acm =

"A %
CMRR = 20log10 $ d '
# Acm &

(2.3)

€

Figure 2.6 High common mode rejection ratio (CMRR) is achieved with well-matched
components and degraded with mismatches. Cascaded amplifier topology was used with
1% matched components (blue). Potential divider effect is observed when 10 pF is added
to one input capacitor to create a 10% mismatch (red).
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The cascaded amplifier topology allows the gain to be distributed in order to maintain
bandwidth and eliminate undesirable DC offset voltages. Electrode-tissue interactions
create DC-potential offsets that can saturate the INA if the gain is too high (187). The
first stage gain is designed for 20 dB (10:1) and measured at 19.99 dB (Figure 2.7, black
trace). With a supply voltage of 1.8 V, the tolerable electrode offset voltages are less than
180 mV. The high pass filter eliminates any DC offsets. The second stage gain is
designed for 40 dB (100:1) resulting in a total gain of 60 dB (Figure 2.7, blue trace). The
total gain is 59.43 dB which is in good agreement with design. The high pass filter is
controlled by R5 and C3. The low pass is controlled by R7 and C4. The respective 3
dB cutoffs are 0.72 Hz and 1.13 kHz. The 3 dB cutoff frequency, fc, can be calculated by
equation 2.4 where R and C are the resistor and capacitor involved in the specific filter.

fc =

€

1
2πRC

(2.4)
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Figure 2.7 Gain and bandwidth of the analog front end. Three conditions were measured
to observe how component addition affected the differential gain. Black = INA333 + the
input low pass filter, blue = cascaded amplifier topology with input filter, red = cascaded
amplifier topology with 10 pF mismatch at the input filter (see Figure 3.6 for CMRR
degradation). High pass 3 dB cutoff frequency = 0.72 Hz, Low pass 3 dB cutoff
frequency = 1.13 kHz. Cascaded amplifier (blue) gain = 59.43 dB in the pass band.

2.3.3

Power Line Noise Reduction

Noise is introduced to the analog front end by magnetic induction and capacitive
coupling of electrical fields (186). From Faraday’s Law, conducting loops allow
magnetic fields to induce an electromotive force (emf). The resulting emf pushes current
and creates noise. Alternating electrical fields displace charges in the electrode leads and
subject’s body. This also results in noise. Typically, the 50 or 60 Hz main power line is
the primary noise source; however, in a wireless powered system, it is important to
consider noise contributions from a the specific powering setup as well. Power line noise
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will first be addressed. Figure 2.8 is the circuit representation of noise coupling into a
two-electrode ground free circuit topology (180). Equation 2.5 represents the total noise
at a specific frequency that is seen by a differential amplifier as depicted in Figure 2.8
(186). The total current seen by the subject’s body due to the power mains coupling
through C1 is represented by id1. The KBS term represents noise from magnetic induction.
K is a constant, B is the magnetic flux density, and S is the loop area that allows magnetic
induction. The ib1Ze1 and ib2Ze2 terms represent the voltage noise caused by capacitive
coupling into the leads. Ze1 and Ze2 represent the impedance of each electrode and ib1 and
ib2 are the currents passing through each branch. Zb is the impedance of the subject’s
body and ib is the current flow in the body. The current from id1 can flow to earth ground
through the subject, id2, or through the common mode impedance (Zcm1 or Zcm2) of the
INA, id3 (typically 1 nA) (180). The final term reflects the voltage noise due to current
flowing through Zcm. The bracketed portion shows the effect of the CMRR and potential
divider effect. The KBS term can be ignored by minimizing conducting loop area with
short connections, shielding, or twisting the electrode leads. This reduces the S term to a
negligible value (assume S = 0). Previously, it has been shown that the currents through
the electrode and Zb are relatively small and can be neglected (180,186). Assuming that
the common mode impedance of the INA is much greater than the electrode impedances
(assume Zcm >> Ze), then remaining factors are the common mode impedance, CMRR,
and potential divider effect. Thakor and Webster previously derived the simplified
equation for a ground free, 2 electrode telemetry configuration (equation 2.6) (180). Zd
represents the mismatch between electrode impedances, and Zcm1 and Zcm2 are assumed to
be equal (Zcm).
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Figure 2.8 Circuit representation of a two electrode ground free biopotential recording
system. Noise from main power lines is coupled through C1 resulting in a current id1. This
current can then flow through the electrodes and be seen by the device, (ib1, ib2, id3) or
flow to the earth ground (id2). See equations 3.5 and 3.6 for the quantification of the noise.

43
From equation 2.6, the voltage noise contributions from the common mode impedance
can be simulated for various CMRRs (5 kΩ electrode impedance mismatch, id3 = 1 nA,
Figure 2.9). In typical instrumentation amplifier settings, it is beneficial to have both a
high common mode impedance and differential impedance. Importantly, in a ground free,
2-electrode configuration, the Zcm can increase the noise for a particular CMRR and
electrode-tissue impedance mismatch (Figure 2.9). This is not an intuitive result and
should be carefully considered. Having an infinite CMRR would minimize the noise, but
this is not realistic, especially when size and power are considerations for INA selection.
Understanding the minimum noise requirements and potential electrode mismatches
defines the CMRR required. Figure 2.10 shows how increasing mismatches in electrode
impedances affect the voltage noise (CMRR = 80 dB, id3 = 1 nA). The closed-loop device
CMRR can range from 80-100 dB depending on the input filter matching (Figure 2.6).
With a 5 kΩ electrode impedance mismatch and 80 dB CMRR, the voltage noise due to
power mains coupling is < 3 µV. A 10 kΩ mismatch increases the noise to 5 µV.
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Figure 2.9 Voltage noise versus common mode impedance. Simulation data from
equation 2.6. A 5 kΩ electrode impedance mismatch, Zd, is used. CMRR from 40 to 100
dB are plotted.

Figure 2.10 Voltage noise versus common mode impedance for various electrode
impedance mismatches, Zd. Simulation data from equation 2.6. 80 dB CMRR is used. Zd
from 100 Ω to 50 kΩ are plotted.
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2.3.4

Minimizing Radiofrequency Interference

Radiofrequency wireless powering of devices introduces a planted noise source
directed at the implantable device. Amplifiers in particular are susceptible to RF
interference at the electrode inputs. If seen by the INA, frequencies in the MHz manifests
as DC offsets and slow drifts. This behavior exists because amplifier inputs act as diodes
in this frequency range and rectify the AC signal into DC or slow AC waves (188). This
can be observed by directly inputting a high frequency differential signal into the INA
inputs. To demonstrate, a signal generator is used to input 1, 10 and 20 MHz differential
signals into the INA with no input filters and only input common mode bias resistors
(Vdd = 3.0, gain = 43 dB (200:1)). Additionally, a reference voltage of 1.5 V was
applied to the output through a unity gain buffer. The output voltage should be centered
at 1.5 V. Figure 2.11 plots the average output voltage detected by an oscilloscope as the
amplitude of the input signal is varied. The output voltage shifts well beyond 1.5 V, and
this can result in undesirable drifting of the output signal and amplifier saturation.
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Figure 2.11 DC offsets and slow drifts caused by RF inputs into the INA. A function
generator inputs 1 (blue), 10 (red), and 20 (black) MHz signals into the input of an INA
with no filtering. The measured output is the average as observed on an oscilloscope. Vdd
= 3 V and the output reference voltage is 1.5 V.
To minimize the RF induced drifts, a low pass input filter is inserted using C1, C2, R1,
and R2 (Figure 2.5). Due to the potential divider effect, the components must be well
matched. Low pass filters require smaller valued components than high pass filters. It is
reasonable to find 1% matched COTS passive components with small footprints to
prevent CMRR degradation. The benefit of the filter is shown in Figure 2.12. The full
analog front end was used for this measurement (Vdd = 1.8 V, Gain = 60 dB). A 1, 4, and
8 MHz differential signal at various amplitudes is applied at the inputs with the signal
generator. These frequencies are used since the wireless powering (Chapter 4) is
performed at 4 MHz. The common mode output voltage is 0.6 V at 100 mV pk-pk input.
For ease of viewing, the common mode output voltage is shifted to 1.6 and 2.6 V for the
500 mV and 1V conditions, respectively. The input filters remove the DC offset and
drifting due to the RF input. The 1 MHz signal is noisier as there is less attenuation.
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Figure 2.12 Prevention of DC drifting due to RF interference. A low pass filter was
inserted into the inputs of the device AFE. A waveform generator is used to pass 100, 500
and 1000 mV pk-pk into the device. The data is digitized and transmitted. The common
mode output voltage is 0.6 V, but the results have been level shifted for 500 and 1000
mV pk-pk signals. This was done for ease of viewing. No DC offsets or drifting is
observed. Device gain is 60 dB

2.3.5

Input Referred Noise

The smallest signal the AFE can measure is determined by the device’s internal
noise. Instrumentation amplifiers have an input voltage noise source, output voltage noise
source, input current noise source, and other external noise sources (i.e. electrodes or
biasing circuitry). The total noise referred to the INA input can be quantified by
equations 2.7 and 2.8 (189). The voltage noise source at the input, eni, is not affected by
the gain, G, of the amplifier, while the voltage noise source at the output, eno, is. The
current source at the input, in, creates noise with respect to the electrode resistance, Re.
Using the INA specification sheet parameters and estimating external noise contributions,
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an approximate noise value referred to input is calculated to be 56.92 nV⋅Hz-1/2. Figure
2.13 shows the measured noise at the output of the second stage of analog front end (blue
line). The noise referred to input is determined by dividing the total output noise by the
gain (black line). At 20 and 200 Hz, the noise referred to input is 68.15 and 49.16 nV⋅Hz1/2

, respectively. Values are well matched to theoretical calculations. To observe the

minimum noise seen by the device, the electrode inputs of the device are shorted and the
resulting voltage is digitized by the MCU. The baseline oscillates between 2 or 3 bits,
indicating signals greater than 14 µV can be observed.

Vn,total =

€

(eni )

2

2 %
" eno
2
2
+ $ ' + (in Re ) + (Vn,external )
#G&

(3.7)

Vn,resistor = 4kB TR

(3.8)
Table 2.2 Noise Referred To Input Parameters

€

Parameter
eni (10 – 1000 Hz)
eno (G = 10)
In (max)
Re,i (i = 1,2)
Vn,external = resistor thermal noise

Definition
Voltage noise source at
input
Voltage noise at output
Current noise source at
input
Electrode resistance
Thermal noise

Value
50 nV⋅Hz-1/2

Total noise

56.92 nV⋅Hz-1/2

200 nV⋅Hz-1/2
100 fA⋅Hz-1/2
10 kΩ
13 nV⋅Hz-1/2 per resistor

kB = Boltzmann’s constant
T = temperature
Vn,total
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Figure 2.13. Total output noise (blue) and noise referred to input (black) of analog front
end. The cascaded amplifier topology is used and noise is measured at the output of the
second stage amplifier (input to the ADC). A dynamic signal analyzer is used with 100
sample averages.

2.3.6

Final AFE Specifications

The ADC within the microcontroller performs the digitization of the amplified
and conditioned signal. The ADC can operate with 8, 9 or 10-bit resolution and operates
with an internal 1.2 V reference. For a fixed gain of 60 dB (1000:1 ratio), the voltage
resolution is 4.69 µV, 2.34 µV, and 1.17 µV for 8, 9 and 10-bit resolution, respectively.
Typically, the 8-bit resolution is used. If 60 dB of gain and no noise are assumed, the
input of the amplifiers require a signal larger than 4.69 µV. The maximum signal that can
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be detected before saturating the ADC is 1.2 mV. As the noise floor seen by the device is
2 to 3 bits, detectable signals are greater than 14.07 µV. Thus, the dynamic range is 38.61
dB. The AFE occupies 7 mm x 7 mm of board space, and with telemetry, the area is
increased to 7 mm x 14 mm. The device draws 1.8 mA RMS (1.8 V Vdd) which equates
to a power consumption of 3.3 mW. The measured specifications of the analog front end
can be found in Table 2.3. It is difficult to compare the AFE of this device to other COTS
or commercially available devices since several of the product specifications are
unreported (Table 2.4). Three important features standout, though. 1) This is the first
implantable biopotential telemeter to offer electrical stimulation for closed-loop
applications. 2) The size and power consumption are significant advancements from
previous devices. When compared to the only non-implantable biopotential telemeter
with stimulation (66), the size is reduced from 37 x 26 x 6 mm and 27 x 24 x 6 mm to a 7
x 14 x 3 mm and the weight from 4.44 g to less than 0.7 g (batteries and wireless
powering not included). 3) The device presented is not limited by battery life and can be
used for chronic applications.
Table 2.3 AFE Measured Specifications
Design Parameter
Input impedance
CMRR
Low input-referred noise

High Gain
Input dynamic range
Size
Power consumption

Specification
100 GΩ (from INA333 datasheet)
80-100 dB
68.15 nV⋅Hz-1/2 (20 Hz)
49.16 nV⋅Hz-1/2 (200 Hz)
60 dB (1000:1)
38.61 dB
7 x 14 x 3 mm (includes
telemetry)
3.3 mW (5 kHz sampling, 1.8 V
Vdd)
33.7 µW/mm2
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Table 2.4 Comparison of AFE to COTS and Commercial Devices
Device
Number of
recording
channels
HP cutoff, Hz
LP cutoff, Hz
Bandwidth, Hz
Sampling Rate

(64)
(TR50BB)
2

Not reported
Not reported
Not reported
Up to 2 kHz

(65)
(HD-S21)
1
biopotential
, up to 2
pressure
0.1
145
0.1-145
Not reported

(66)

(67)

This work

1

7-8 or 1416

1

0.32
80
0.32-80
200 Hz

4-300
3000
4-3000
20 kHz:
14-16
channels

0.72
1132
0.72 - 1132
5 kHz

Gain, dB20
Input referred
noise
Telemetry

Not reported
Not reported

Not reported
Not reported

60
Not reported

Yes; digital

Yes; digital

Yes; digital

Electrical
Stimulation
channels
Device
components
Implantable?
Power
consumption
Powering Source

None

None

COTS

Battery Life, hrs
Size (L x W x H)

Weight, g

40 kHz: 78 channels
54-90
2.2 µV

60
~2.3 µV
Yes; digital

Yes

Yes;
digital
None

COTS

COTS

COTS

COTS

Yes
Not reported

Yes
Not reported

No
31.8-54 mA

Yes
3.3 mW

Rechargeable
battery; inductive
powering

Battery

Battery

No
Not
reported
Battery

4-7
28.5 x 24 x 10.5
mm

2 months

Not reported
Neural interface
board:
37 x 26 x 6 mm

13

5.9 cm3

8

2.4

MCU board:
27 x 24 x 6 mm
4.44 (not
including
battery pack)

1.5
35 x 35 x
35 mm

22

Yes

Wireless;
magnetic
resonance
powering
No battery
7 x 14 x 3
mm

< 0.7 g
(powering
board not
included)

Constant Current stimulator

The function of a constant current stimulator is to deliver information to neurons
through an electrical stimulus. Critical parameters for stimulators are: charge balanced
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waveforms, safety under fault conditions, and controllable parameters (pulse width and
amplitude). The stimulator topology is a current sink with switches to control the
polarity (Figure 2.14) (190). A blocking capacitor is placed between one electrode and
the switch to limit charge injection under fault conditions, maintain charge balance, and
block DC currents (191,192). Additional blocking capacitors can be placed at each
electrode as a safe practice. MCU timers are used to control the pulse width and
frequency of stimulation while a digital to analog converter (DAC) outputs a reference to
control the current amplitude.
The stimulator topology maintains a constant current by the feedback to the
operational amplifier. When switch A connects the Vref and Va nodes, the operational
amplifier will drive the MOSFET until Vb = Va. Since Vb is equal to Vsense, the amplitude
of current can be controlled with Vref and is equal to Vref / Rs. Given enough voltage head
room to drive the load across the electrodes, the current will be held constant at the
desired amplitude. The first generation topology can drive 1.316 mA across a 1.026 kΩ
load (Figure 2.15). The MCU control logic of stimulation parameters is shown in Table
2.5. During the initialization, no current is passed. At event 1, the switches are configured
to pass current through the electrodes in one polarity and then toggled at event 2 to flip
the polarity. At event 3, both electrodes are tied back to Vdrain.
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Figure 2.14 Constant current stimulator topology. The opamp wil drive the MOSFET
until Va = Vb. Current amplitude can be calculated by dividing Vref by Rs. An additional
DC blocking capacitor can be placed on electrode 2. Blue label indicates blocks that are
controlled by the MCU. Switch operation is detailed in Table 2.5.
Figure 2.16 demonstrates fast stimulation at 1 kHz with 200 µs pulse widths. The
frequency of pulsing is much greater than the typical deep brain stimulation paradigm
(100-200 Hz). As some applications require more headroom to pass more current, a 2nd
generation stimulator is designed that can handle a 12 V supply. The increased supply
voltage provides voltage headroom to pass a minimum of 1 mA through a 10 kΩ load.
Figure 2.17 compares the driving capabilities of the 1st and 2nd generation stimulators
across a 10 kΩ load. The differential voltage measured in Figure 2.16 and Figure 2.17
were acquired with an oscilloscope probing the voltages at the output of electrode 1 and
electrode 2. The two voltages were then subtracted.
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Figure 2.15 Linear control of current of constant current stimulator. Rs = 497.8 Ω, Vdd = 2
V, Rload = 1.026 k Ω. The current plateau is 1.316 mA.

Table 2.5 Control Logic of Stimulation Parameters
Electrode 1
Electrode 2
Va

Initial
Vdrain
Vdrain
Gnd

Event 1
Vdd
Vdrain
Vref

Event 2
Vdrain
Vdd
Vref

Event 3
Vdrain
Vdrain
Gnd
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Figure 2.16. Biphasic stimulation pulse train. Stimulation is across a 11 kΩ load.
Stimulation parameters are: 200 µA, 200 µs pulse width, 1 kHz period. Differential
voltage is the voltage across the load.

Figure 2.17 Comparison of the 1st generation and 2nd generation constant current
stimulators. The first generation stimulator (black, left) is driving a 10 kΩ load with 200
µA (100 µs pulse width). The second generation CCS (blue, right) is driving a 10 kΩ
load with 1 mA (200 µs pulse width).
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2.4.1

Final Constant Current Stimulator Specifications

The measured specifications of the constant current stimulator are shown in Table
2.6. Programmable features include pulse width, frequency, current amplitude, and
duration of stimulation. Experimental DBS protocols range from 1 Hz to 200 Hz
stimulation (72-75). The maximum driving current is determined by the load and voltage
headroom provided by the stimulator supply voltage (Vdd). As previously discussed in
Section 3.3.1, electrode impedances can vary significantly in vivo. Clinical DBS
macroelectrodes range in impedance values from 500-1500 Ω (193). Microelectrodes,
though, can have impedances in the tens of kΩs (182). Increasing the voltage headroom
for the 2nd generation stimulator allows experimenters to drive 1 mA across a 10 kΩ load,
exceeding the typical drive currents of a few hundred µAs. Table 2.7 compares this work
to other COTS implantable stimulators from Table 1.2. For brevity, non-implantable
devices are not included. This work meets the specifications of other COTS stimulators,
and excels in size and operating lifetime, as it does not rely on batteries. While it does not
provide 2 channels of stimulation, this device includes a biopotential acquisition channel
for closed-loop operation. It is difficult to compare current driving capacity as loads are
not specified in other works. The measured specifications show that the CCS presented in
this work is suitable for implantable chronic experiments.
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Table 2.6 Final Specifications of the Constant Current Stimulator
Parameter
Minimum Pulse width
Frequency
Stimulation current
Vdd = 1.8 V
Vdd = 2 V
Vdd = 3 V

Condition

Rs = 499 Ω
Rload = 1 kΩ
Rload = 1 kΩ
Rload = 1 kΩ

Vdd = 12 V
(2nd generation)
Biphasic Stimulation

Rs = 200 Ω
Rload = 10 kΩ

Footprint (L x W x H)

Specification
8 µs
1-10 kHz
1.2 mA
1.3 mA
2.0 mA

1.0 mA
Yes
6 x 5.5 x 3 mm

Table 2.7 Comparison of CCS to COTS and Commercial Devices
(81)
Device
Number of
stimulating
channels
Biphasic
stimulation?
Power Supply,
V
Programmable?

(82)

(84)

(78,80)

This Work

1

1

2

1

Yes

Yes

Yes

Yes

Yes

4.65

5V
compliance
Yes;
inductive
powering
rectification
100-500

3

3.6

1.8 – 12 V

Yes; wireless

Yes; tethered

Yes; wireless

50-600

13-1000

131

2-500

120 – 1000
(10 kΩ load)
1-10000
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0-100% of
period
No

8 µs to 100%
of period
Yes; digital
radio

None

Yes

No

Yes;
telemetry

2

Yes; not
wireless

Stimulation
current, µA
Stimulation
frequency, Hz

20-100

Pulse width
duration, µs
Telemetry

60

Not
reported;
stimulation
current rise
time is 10
µs
50-250

No

No

None

None

Yes; inductive
near field
communication
None

Yes;
magnet

Yes;
inductive
powering

Yes; inductive
near field
communication

Electrical
recording
channels
On / Off switch

131
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Implantable?
Power
consumption

Yes
Not
reported

Yes
Not
reported

Yes
Not reported

Yes
Not reported

Yes
@1.8 V, 90
µW during
off periods
@12 V, 600
µW during
off periods

Powering
Source

Battery

Inductive
powering

Battery

Rechargeable
Battery

Battery Life
Size (L x W x
H)

2 months

14 x 22 x 6
mm

3-5 weeks
20 x 38.5 x
13.5 mm

10 days
33 x 20 x 8
mm

2.5

~13

11.5

Weight, g

8 mm
diameter,
30 mm
length
2.1

2.5

Stimulation
power is
depending on
active current
Wireless;
magnetic
resonsance
powering
6 x 5.5 x 3
mm

< 0.7 g (no
powering
board
included)

Microcontroller and Telemetry

An ARM Cortex-M0 Nordic microcontroller (MCU) acts as the brain of the device.
The MCU digitizes the output of the AFE and telemeters the data. The devices are
configured with a total sampling rate of 5 kHz. The telemetry is setup to transmit 40 kbps
and the MCU can support up to 2 Mbps (194). Similar to the firmware for the optogenetic
device (Chapter 3), interrupt based logic is used to maintain low power consumption and
sleep states. The fidelity of telemetry with respect to range and orientation of the antenna
is an important consideration. By designing at a miniature scale, the manufacturer
recommended antenna circuit board layout technique must be modified. To quantify
packet loss, the device is placed in three orientations (in line, perpendicular, and standing)
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with respect to the basestation (Figure 2.18). The packet loss is measured over 20 second
intervals. The packet loss is less than 3% in most orientations and distances and less than
1 % in orientations 1 (in line, blue) and 2 (perpendicular, grey) at a distance of 12 inches.
Packet loss is the worst with orientation 1 at 48 inches (12.5% loss) and position 3
(standing) at 24 inches (4.3% loss). To better understand losses in future iterations, the
antenna radiation pattern should be measured in an anechoic chamber.

Figure 2.18 Packet loss with respect to distance for 3 device orientations. The device is
parallel and inline (blue), perpendicular (grey), or standing (black) with respect to the
basestation. Losses were measured at 12, 24 and 48 inches.

2.6

In vivo validation

Validation of device blocks in vivo is performed acutely and chronically in rats.
All procedures were approved by the Purdue Animal Care and Use Committee (PACUC)
under protocol 1112000339. For acute experiments, female adult Long-Evans rats were
anesthetized with urethane (0.7-1.2 mg/kg, IP) and given butorphanol (0.5-2mg/kg, SC).
The relevant biopotentials in this work are: ECG, external intercostal EMG for
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respiration rates, LFP, and EEG or ECoG. Subsections of 2.6 will address each
biopotential measurement. EEG and ECoG are categorized together as the frequency and
amplitude content are similar.
The devices used for validation are a 1st generation device with 1 channel
recording and 1 channel stimulation, and a 2nd generation device with 2 channels of
recording and 1 channel of stimulation. The 1st generation device is characterized in
Sections 2.1-2.5 and will be named device 1 (D1). The 2nd generation device is an
extension of this work and will be named device 2 (D2). A DC power supply provides
power at 1.8 V for both devices. The bandwidth of D1 is designed for 0.7 Hz to 1 kHz,
while the bandwidth for D2 is 8 Hz to 1 kHz. Gain for both devices are set to 60 dB. Both
devices are sampled at 2.5 kHz per recording channel. A GRASS amplifier (GA) is used
for comparison. Various GA gain and bandwidth settings were used to observe the
desired signal of interest. The GA low pass cutoff was always set to 10 kHz and sampled
at 20 kHz. For the LFP validation, D2 is used to both stimulate and record to demonstrate
both functionalities in the device.

2.6.1

Electrocardiogram in vivo Validation

Stainless steel leads are placed intramuscularly the lead 1 configuration (Figure
2.19). After suturing in the leads to prevent displacement, the leads are fed to a connector.
The connector is used to exchange input connections between the GA, D1, and D2.
Simultaneous measurements are not made to prevent undesired loading between
amplifiers. Figure 3.19 compares the lead 1 ECG recording between the GA, D1, and D2.
The order in which data was acquired is D1, GA, and then D2. Figure 3.19 compares the
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3 acquisition systems for a 7 second recording (left) and a 1 second recording (right). The
P wave, QRS complex, and T wave are all distinctly visible in all 3 recordings. The QRS
distortion (M shaped-wave and lower amplitude) seen in the GA recording is caused by
the 60 Hz input notch filter and can be avoided in future experiments by switching off the
filter. In the 7 second D2 recording, a slow ~0.5 Hz oscillation is observed. This is a
motion artifact associated with the breathing rate of the subject. Due to D1’s lower
highpass filter, this signal is seen in D1 and not D2. Interestingly, the heart rate
decreases from D1, to GA, to D2, which is the order of recording. In 7 seconds, the
number of heartbeats is 25, 21, and 19 for D1, GA, and D2, respectively. While urethane
anesthesia should maintain steady cardiopulmonary physiology (195), cardiac depression
has been previously observed (196). D1 and D2 are both suitable for ECG acquisition in
vivo.

Figure 2.19 ECG Lead 1 Measurement Setup. The GRASS amplified (GA) uses 3
electrodes. Two differential (blue) and a common mode (green) electrode. Device 1 (D1)
and Device 2 (D2) only use the differential electrodes.
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Figure 2.20 Comparison Between Acquisition Systems. Lead 1 recordings from a
GRASS amplifier (GA), Device 1 (D1), and Device 2 (D2). 7 second recordings are
pictured on the left and 1 second recordings on the right. Leads are sutured
intramuscularly and switched between amplifier systems. The order of recordings is D1,
GA, D2.
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2.6.2

Electromyogram in vivo Validation

Respiration rate activity can be observed by measuring the EMG of the external
intercostal muscles (49,197). Stainless steel leads are placed intramuscularly in the right
external intercostals. The same connector setup for ECG validation is used (Section
2.6.1). Figure 2.21 shows EMG and ECG recordings at the mid-thoracic right external
intercostal muscle. The order of recording was GA, D1, and then D2. The GA’s high pass
was increased to 10 Hz to eliminate motion artifacts that are visible in the raw D1 trace
(blue). No digital filtering was required on the GA. D1 and D2 have noisier recordings
and are both high passed at 100 Hz with a digital second order butterworth filter. Raw
traces for D1 and D2 are shown in blue, and post filtering is in black. The high pass filter
drops the signal common mode to 0 V. The signal quality of the GA is superior. The
common mode electrode of the GA provides increased noise rejection. However, the
EMG signature is still observable by D1 and D2. From this data, it can be seen that
respiration is occurring at approximately 1 Hz.

64

Figure 2.21 External intercostal EMG’s recorded by the grass amplifier (GA), device
1(D1) and device (D2). For D1 and D2, the blue signals are raw and the black signals are
high pass filtered at 100 Hz. The high amplitude spikes are QRS complexes. The left
figures show 9 seconds of data while the right displays only 3. The EMG activity can be
detected with all three measurement systems.

2.6.3

ECoG Evoked Potentials in vivo Validation

To observe cortical neural activity, the EEG or ECoG is often used. Cortical
evoked potentials can be observed if an upstream portion of the neural network is
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electrically stimulated. Evoked potentials have been used to map pathways in epileptic
patients (198), and the method is used here to elicit cortical activity for observation. The
cingulate cortex is a downstream site of the classic Papez circuit (199) and should be
activated by stimulation at the fimbria or fornix. In this validation experiment, a stainless
steel bipolar twisted pair of recording electrodes is placed at the surface of the left
cingulated cortex (AP: 1 mm, L(left): 0.5 mm, DV: -1 mm from skull surface; bregma
reference). A bipolar stainless steel bipolar twisted pair for stimulation is targeted at the
fimbria-ventral hippocampal commissure white matter tracts (AP: -1.3, L(left): 0.2 mm
DV: -4.5 mm from brain surface; bregma reference). A commercial stimulator was used
to activate the fimbria-ventral hippocampal commissural axons (3 Hz stimulation, 200
µA, 200 µs pulse width). Figure 2.22 compares the evoked potentials at the surface of the
left cingulated cortex. The recording progression was GA, D1, and then D2. The D2
recording had a large amount of 60 Hz noise. As a result, a digital IIR notch filter was
used. The raw data is shown in blue and the filtered signal in black. It seems that larger
evoked potentials are observed in D1 and D2 when compared to GA. Figure 2.23 shows
each evoked potential from a trial aligned and then averaged (thicker black line). It is
clear that the GA plot has a lower amplitude. It is possible that as the GA was used first
for recording, sufficient time had not passed to recruit neurons for a larger response. In
all 3 recording systems, evoked potentials can be seen 3 ms after the stimulation artifact
(aligned at 10 ms, Figure 2.23). In D1 and D2, a valley is seen at 15 ms after the
stimulation artifact, and then second peak at 30 ms (Figure 2.23, overlay, red and blue).
The recordings in D1 and D2 are in good agreement; however, it is unclear why the GA
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response is different. As evoked responses can be experimentally difficult to maintain,
future setups should simultaneously record the same signal.

Figure 2.22 Evoked potentials recorded by the grass amplifier (GA), Device 1(D1) and
Device 2 (D2). Electrodes were placed at the surface of the left cingulated cortex. A
commercial stimulator was used to activate the fimbria-ventral hippocampal commissural
axons (3 Hz stimulation, 200 µA, 200 µs pulse width). The left figures show 10 seconds
of data while the right only 0.8 seconds. The blue traces are raw data in all three figures.
D2 required a 60 Hz digital notch filter.
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Figure 2.23 Averaged evoked potentials from Figure 2.22. Evoked potentials were
aligned and averaged. The GA is recorded first, then D1 and then D2. Bottom right
overlays the averages for each recording system (GA = black, D1 = blue, D2 = red).
2.6.4

LFP Evoked Potential in vivo Validation

The local field potential can be observed using depth electrodes. Using a similar
setup to Section 2.6.3, evoked potentials are recorded at the ventral hippocampus (AP: 5.2 mm, L(right): 4.5 mm, DV: -5.5 mm from brain surface; bregma reference).
Stimulation is at fimbra-ventral hippocampal commissural axons (same as Section 2.6.3).
In this validation, Device 2 is used to both stimulate (200 µA, 200 µs pulse width) the
axons and record the evoked response. Figure 2.24 shows overlapped and averaged
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evoked potentials recorded at the right ventral hippocampus. The data is notch filtered to
reduce 60 Hz noise. Each color represents one evoked potential and the thicker black
trace is the average response. The peak is 30 ms after end of stimulation. The D2
stimulation caused the amplifier to saturate and any earlier peaks are missed. This data
shows that the 2nd generation stimulator can deliver sufficient current to the tissue, and
that the same device can record the response shortly after.

Figure 2.24 Evoked response recorded using only D2. The fimbria ventral hippocampal
commissural axons are stimulated. The response is recorded in the right ventral
hippocampus. The data is notch filtered to reduce 60 Hz noise. The peak is 30 ms after
end of stimulation.

2.6.5

Multichannel Chronic in vivo Validation

The closed-loop device can be redesigned into a 2-channel biopotential device.
Two of these devices (Device A and Device B) are used to collect chronic data from a rat
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for preliminary experiments in SUDEP. A RF wireless powering board is mounted next
to Device A (Figure 2.25). The power board has a coil receiver that couples energy from
a larger source coil. The RF energy coupled is rectified into a DC source. Capacitors (not
shown in Figure 2.25) smooth the voltage, and a 1.8 V linear dropout (LDO) regulator
provides a stable power supply to both Device A and Device B. The powering board and
Device A are implanted on the rat’s flank and leads are routed subcutaneous and sutured
intramuscularly in lead I and lead II ECG configurations. Device B is routed
subcutaneous to the skull and measures LFP from the left ventral hippocampus and
ECoG from the contralateral motor cortex. Twisted pair platinum electrodes are used for
the LFP and stainless steel bone screws for the ECoG. The transmit powering coil is a
single solenoid wrapped around a cage. An example dataset is shown in Figure 2.26. This
experiment was performed in collaboration with Professor John Jefferys at the University
of Oxford. In Figure 2.26, it is clearly shown that 2 implantable devices can
simultaneously acquire 4 channels of biopotentials. This is crucial for experiments in
SUDEP as correlating seizure activity to respiratory and cardiac abnormalities is a key
goal.
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Figure 2.25 Fully Implantable Device for Multichannel Biopotential Acquisition. a) The
RF wireless powering receiver circuitry consists of an inductor antenna fed to a rectifier.
The rectifier converts the RF signal is converted to a DC voltage. Capacitors (not shown)
buffer the rectifier output and a single 1.8 V regulator creates a stable supply for Device
A and Device 2. Device 1 acquires 2 lead configurations of ECG and Device B acquires
ventral hippocampal LFP and ECoG from the contralateral motor cortex. b) Image of the
powering circuitry tied to a Device 1. The star marks the coil receiver. The green board is
Device 1 and the yellow board is the powering circuitry. The black wires provide power
to Device 2 (not pictured). The coil is 15 mm in diameter. The black bar is 5 mm.

Figure 2.26 Chronic in vivo Validation of Multichannel Biopotential Acquisition. 4
channels of biopotentials are simultaneously acquired from 2 implanted devices. Clear
ECG, ECoG, and LFP activity can be observed.
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2.7

Pressure Monitoring for Urinary Urge Incontinence

Urinary incontinence is the inability to control the bladder. Previously, it has been
shown acutely that the bladder can be controlled by deep brain stimulation in the
periacqueductal grey (PAG) area in both rats and humans (174). Before pursuing chronic
human studies, chronic animal validation studies are required. The proposed closed-loop
system would measure bladder pressure and stimulate based upon a threshold to prevent
urination. As a proof-of-concept experiment, a device development board was
reconfigured to operate with a Bremen capacitive pressure sensor. When pressure is
exerted on the membrane of the sensor, the distance between the end plates is reduced.
This results in a detectable change in capacitance. For the experiment, the capacitive
pressure sensor and development board are used to monitor acute changes in bladder
pressure in an anesthetized rat. The Bremen pressure sensor (now owned by Protron
Mikrotechnik) and measurement IC are provided by the manufacturer. For integration
into the device platform discussed in previous sections, the packaged sensor and
measurement IC can communicate to the Nordic MCU with already available general
purpose digital input output pins. Figure 2.27 shows the surgical setup. An infusion pump
delivers saline into the bladder at a rate of 6 mL/ hr. A reference sensor and the capacitive
sensor are measuring pressure from a T piece of tubing. A GRASS amplifier monitors the
EMG of the external urethral sphincter and the experimenter visually monitors the urine
output. The urine output is recorded with a clicker and the entire voltage pulse indicates
urine output from start to finish. Figure 2.28 shows the experimental data. First, both
sensors are shown to be linear in the 0-40 mm Hg pressure range. The capacitive sensor
is noisy and smoothing function is used (Figure 2.28b, blue = raw, black = smoothed
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data). As can be seen, the smoothed data shows the features of the raw data. As saline is
infused, the pressure in the bladder increases. A critical threshold is reached and then the
EUS activates and urination occurs. The data from the experiment is in good agreement
with previous animal experiments (174). The platform is able to detect this reliably and
integration into a device form for closed-loop control of urinary incontinence is possible
with the presented technologies.

Figure 2.27 Surgical setup of the in vivo experiment. The Bremen sensor is connected to
the device (development board). A tube runs from the bladder to the sensor and is air
filled at the base to prevent fluid entry into the device. The same tube is split to a
reference sensor. The device samples at 54 Hz and wirelessly transmits the data to the
basestation. The reference sensor is sampled at 500 Hz by the data acquisition unit
(DAQ). A grass amplifier sampled at 500 Hz measures the EMG from the external
urethral sphincter, and a visual detection is used to mark periods of urination. An infusion
pump steadily flows saline into the bladder at a flow rate of 6 mL/hr.
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Figure 2.28 Pressure sensing in vivo validation. a) Air chamber calibration data for a
capacitive sensor (black) and reference sensor (red). The pressure was increased with a
custom manometer. Capacitive sensor data points are 20 point averages and were
measured by a LCR meter (Agilent) with 1 MHz, 1V excitation. b) In vivo pressure
measurements with the capacitive sensor require smoothing. The blue trace is raw data
sampled at 54 Hz. The black trace is a moving average with a 54-sample window. The
smoothed data agrees with the raw data trends. c) A trial observing an empty bladder
slowly fill and increase in pressure until urination is observed. d) A trial observing the
bladder continually urinate. In vivo bladder pressure from the reference sensor (red) and
capacitive sensor (black) are in good agreement in both (c) and (d). The pressure drops as
urination occurs and the external urethral sphincter activates. The pulse width of the urine
markers (blue) indicates the total time of urination. The first mark is the beginning of the
trial. EMG data is collected with a grass amplifier sampled at 500 Hz.

2.8

Conclusion

The platform technologies for sensing of electrical signals and providing electrical
stimulation have been verified on the bench and validated in vivo. The technologies
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create a useful and flexible platform for researchers to investigate wide ranging
neurological and psychiatric diseases in rodent models. For use in epilepsy, optimization
of closed-loop electrical stimulation to increase efficacy and understanding the important
features needed in seizure suppression is of great need. To the author’s knowledge, the
first implantable device with 1 channel biopotential acquisition and 1 channel stimulation
is presented. In SUDEP, preliminary experiments show that with two devices, 4 channels
of biopotentials can be simultaneously acquired chronically. This experiment paradigm
can help to address mechanistic questions involving sudden death. For urinary urge
incontinence, pressure sensing in vivo is demonstrated acutely. Integration of the sensor
into the device for chronic implementation is the next step in creating a closed-loop
device to control mictruition.
The individual building blocks of the analog front end, constant current stimulator
and microcontroller are modularly integrated into a family of 1st generation devices. With
slight modifications to the circuitry to reduce size and share resources, other device
systems can be designed for specific applications. Additionally, the optical stimulator for
use optogenetics (Chapter 3) can be driven with the CCS. A wireless, closed-loop optical
stimulator for use in optogenetics would be of great use to the research community. Table
2.8 lists a family of devices based on the core technologies presented and the possible
applications. Applications in blue have been studied or are currently under study with
these devices.
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Table 2.8 Family of Devices and Possible Applications
Device

Features

Programmable Parameters

Possible Applications

Closed Loop
Deep Brain
Stimulator
(DBS-CL)

• Biphasic

• Current per phase of

•
•
•
•

Closed Loop
Optogenetic
Stimulator
(OGS-CL)

Open loop DBS
(OL-DBS)
Open loop
optogenetic
stimulator (OLOGS)
Recording only

Electrical
stimulation
• 1-2
differential
recording
channels
• On board
MCU

•
•
•
•
•

stimulation
Frequency of stimulation
Duty cycle of stimulation
Duration of stimulation
Feedback algorithms
Feature detection
algorithms on the MCU

• LED based

• Stimulating current

• 1-2 channels,

•
•
•
•
•

stimulation

differential
recording
channels
• On board
MCU
• Biphasic
electrical
stimulation
• LED based
stimulation

• 1-2 channels

differential
recording
• Tie two
devices
together for 4
channels

amplitude
Frequency of stimulation
Duty cycle of stimulation
Duration of stimulation
Feedback algorithms
Feature detection

• Same as DBS-CL but

without feedback or
feature detection
• Same as OGS-CL but
without feedback or
feature detection

•
•
•
•
•
•
•
•
•
•
•

Parkinson’s disease
Epilepsy
SUDEP
Vagal nerve
stimulation (VNS)
Autonomous neural
control (ANC)
Addiction
Urinary
Incontinence
Social behavior
Anxiety
Autism
Fear
Depression
Sleep/wake cycles
Memory
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CHAPTER 3. A MINIATURE, FIBER-COUPLED, WIRELESS DEEP-BRAIN
OPTOGENETIC STIMULATOR

The data and work in this chapter is accepted for publication in the IEEE Transaction of
Neural Systems and Rehabilitation Engineering (PMID: 25608307) . The citation can be
found in the CV. This chapter is primarily a reproduction of the publication and has been
reformatted for the dissertation © 2015 IEEE (200). This work was performed in
collaboration with Dr. Simon John and Dr. Da-Ting Lin at The Jackson Laboratory.

3.1

Introduction

Optogenetics is a powerful core methodology for dissecting neural circuits (201).
Pairing of miniature and wireless optoelectronic systems can enhance the rapidly
expanding optogenetic (202) and electroceutical (203) toolboxes. In this work, a novel
optogenetic stimulator (OGS) is presented for use in rodents. This is a lightweight,
miniature, expandable, power efficient, wireless and low cost device to offer control of
stimulation parameters with demonstrated deep brain targeting in rodents. Pairing of this
technology to a biopotential acquisition device (Chapter 2) would allow closed-loop deep
brain optical stimulation. The stimulator is expected to allow many experiments that are
not currently practical. Section 3.2 details the modular hardware blocks. Section 3.3
describes the in vivo validation with transgenic mice in a conditioned place preference
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behavioral test. Section 3.4 follows with a brief discussion, and Sections 3.5-3.7 focus on
the materials and methods. The novel contributions from this work are:
1) A new, low profile fiber coupling technique
2) A wireless platform technology for deep brain optical stimulation
3) One of the earliest demonstrations of behavioral modification in mice due to
wireless deep brain optical stimulation with optogenetics

3.2

The Optogenetic Stimulator

The OGS is a modular solution (3 modules: optical, control, and power) that
consists of a cranially mounted fiber-coupled LED, an ultralow power microcontroller
(MCU) to control stimulation protocols, a wireless link to trigger stimulation, and
rechargeable solid-state batteries (Figure 3.1a).

3.2.1

The Optical Module

Targeting of deep brain structures is essential to the study of behavior (112,204)
and disease (e.g. Parkinsonian circuitry (201) and epilepsy (85,115)). The optical module
achieves this by coupling an optical fiber (core diameter = 200 µm; numerical aperture =
0.39) to an LED (Figure 3.1c,d). Since optical throughput is limited by the relatively
narrow acceptance angle (numerical aperture) and small surface area of the optical fiber,
previous tethered LED fiber-coupled strategies had poor coupling efficiencies and
required a driving current of 1.0 A for 27 mW/mm2 irradiance (465-485 nm) (99). With
the presented fabrication methods, the same irradiance level can be achieved while
providing 21.01 mA of current to the LED (~50-fold current reduction, Figure 3.3a). This
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irradiance level readily activates channelrhodopsin-2 (requires 1 mW/mm2 of 473 nm
light (8)).

Figure 3.1 The optogenetic stimulator (OGS) modules and full system. a) Block diagram
of the OGS. The Passive radio (dashed line) can be removed if not needed. Solid-state
batteries in parallel with a capacitor is used to provide continuous power. A MCU and
current driver are used to control the LED stimulation protocol. Red = power module,
black = control module, blue = optical module. b) A rendering of the OGS fully
connected. c) Connecting the 3 modules: power, control, and optical. The optical module
is depicted with corner cut away to show the coupling of the LED to fiber-ferrule. Inset is
a cross sectional perspective of the optical module. d) Control modules for wireless (left)
and internal triggering (middle). Since the internally triggered device does not require a
passive radio, the antenna and rectifier are removed from the device. This makes the
control module even smaller. The optical module (right) with a fiber-ferrule directly
coupled to a LED. MCU = microcontroller. CCD = constant current driver. For
alternative module configurations, see Figure 3.2. Side view of wireless control module is
provided in Figure 3.2a.
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LEDs are used due to the form factor, narrow emission spectrum, rapid rise time
(nanoseconds), consistent light output, lifetime, and safety. Since the surface area ratio of
the fiber to LED package is < 1, the most efficient optical coupling is achieved by
directly butting the fiber to the light source (205). This is realized with a modified fiberferrule approach. A circularly packaged, reverse mounted LED is embedded in a printed
circuit board (PCB) and a shaved ferrule is mounted through the opposing side (Figure
3.1c). This novel module is fabricated with two concentric through holes of differing
depths (1.5 mm and 0.75 mm) and diameters (1.25 mm and 2.00 mm, respectively) to
align and hold the fiber and LED. Temperature at the bottom (ventral) surface of the
optical modules adjacent to the optical fiber only increased by ≤ 0.80 oC under different
conditions that are far more exacting than those used in the in vivo validation experiments
below (Figure 3.3d, e), and temperature changes at the skull would be considerably less.
To the author’s knowledge, this is the first cranially mounted optical module with LEDfiber coupling to allow power efficient, tether free, deep brain targeting.

3.2.2

The Control Module

Controllable optical stimulation enables more sophisticated stimulation protocols.
It allows desired setting of various frequencies, pulse widths, irradiances, and patterns.
The control module is designed for user programmability of stimulation algorithms and
management of power consumption. An ARM Cortex-M0 MCU is interfaced with a
constant current LED driver to offer control over the frequency (Figure 3.3b), pulse width
(Figure 3.3c), and optical irradiance of stimulation. The optical and temporal parameters
can be defined with microwatt and sub-millisecond resolution, respectively. Since the
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optical output power is linearly proportional to the input driving current to the LED
(Figure 3.3a), the digitally programmable constant current driver (14 steps from 1.8 –
20.0 mA) predictably controls the optical irradiance emitted from the optical fiber.
During periods with no stimulation, the device turns off all unneeded MCU peripherals
and enters a deep sleep state consuming less than 7 µA (3.3 V supply, < 23.1 µW).
Within a stimulation train, the MCU is awake during stimulation and is in sleep for the
remainder of the period. Deep sleep wake up times are dependent on MCU
configurations (0.056 – 7.0 ms; see NXP Application Note AN11027). Internal MCU
timers or an external wireless trigger from the passive radiofrequency receiver (Figure
3.2a) can wake the MCU from deep sleep for stimulation. Using the internal timers, in
vivo validation was performed with looping algorithms for periodic trains of stimulation
(deep sleep wake up time = 7.0 ms).

3.2.3

The Power Module

Ultra-low power consumption and low duty cycle operation open avenues for a
variety of powering strategies. Previous optogenetic device studies have used RF
radiative far field powering (42), inductive powering (40) or coin cell batteries (39)
individually. Here, a more robust technology for behavioral experimental paradigms is
used: rechargeable solid-state batteries that are non-cytotoxic, lightweight and thin
(Cymbet Corporation). Two 50 µA-Hr batteries were stacked in parallel to provide
current to the device. A tantalum capacitor delivers the surge currents required during the
1 s stimulation train. The capacitor is recharged during deep sleep states (no stimulation
periods).
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Figure 3.2 OGS modularity allows various configurations. a) 2.4 GHz monopole antenna
(black arrow) used with a rectifier and comparator to trigger the MCU. This is a side
view of wireless control module shown in Figure 3.1d. Additional ceramic capacitors
(black asterisk) are placed next to the bottom connector. b) Supercapacitor modification
for the power module. Two supercapacitors (14 mF, white arrows) stacked in series. This
module can be used in certain experiments if more charge needs to be delivered than the
tantalum capacitor can provide. White asterisk = Power connector. c, d) Optional surface
mount package, 8mm x 8mm) used instead of bare die (5.7mm x 6.1mm). The surface
mount package is slightly larger but easier to fabricate (see Figure 4.3f for comparison to
bare die package). e) Plot of capacitor values versus pulse current at various pulse widths.
Blue = 2 ms, black = 10 ms, red = 20 ms, aqua = 80 ms. f) Recharge time required
specific capacitor values with various numbers of batteries, Recharge voltage = 4.1 V.
Blue = 1 battery, black = 2 batteries, red = 3 batteries, aqua = 4 batteries. Scale bars a =
5 mm; b = 2 mm.
Capacitor sizing can be designed for a single or train of current pulses. This is critical in
providing the proper current and stimulation frequency (Figure 3.3e, f). Designing for a 1
s train of 4 ms pulses (10 mA, 20 Hz), a single continuous pulse of 80 ms as a worst case
is assumed (see Section 3.5.3). The within train pulse rate is limited by the MCU wake up
time and not the capacitor. The minimum capacitor was 795 µF and 1 mF was used. With
two batteries, ~8.4 s are required for recharge between trains (Figure 3.2f), and 59 s was
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provided. Additionally, recharge occurs between pulses. The batteries provide allow
closed experimental setups that are not RF compatible can be used. Miniature and
lightweight systems are critical for use in rodents to allow freely moving behavior. When
completely connected, the OGS configuration used for in vivo validation is 12 x 7 x 11
mm3 (L x W x H) and weighs <1.6 g. The mice are freely moving and unrestricted
(Figure 3.3f, g).

Figure 3.3 OGS characterization for control of stimulation parameters. a) Irradiance of
optical modules (n = 41) with respect to input current. Solid black line = average, grey
shading = 95% confidence intervals, dotted lines = maximum and minimum.
Measurements made with PM100D (Thorlabs) power meter. b) Controlling stimulation
frequencies with the microcontroller (MCU) and constant current driver (CCD).
Normalized amplitude is the analog response of the power meter from an uncoupled LED
connected to the control module. Green = 50 Hz, blue = 30 Hz, black = 20 Hz. 20 pulses
each. c) Controlling pulse widths with the MCU and CCD. Each trace is a single pulse at
20 Hz. Black = 2 ms, red = 3 ms, blue = 4 ms, green = 5 ms. d, e) heating from bottom
surface of optical modules (n = 5) after 3 minutes of constant stimulation (d: 10 ms pulse
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width, 20 mA; e: 20 Hz, 10 ms pulse widths). Measurements were made at room
temperature (22-24 oC). Dotted lines are least square regressions. Error bars are standard
errors. f) OGS used for in vivo validation on freely behaving mouse. Since wireless
triggering was not needed, the smaller internal triggering control module was used, g)
Mice can be grouped housed.
3.3

In Vivo Validation

Device validation in vivo was performed using a well-validated three chamber
conditioned place preference (CPP) paradigm (112,206). Mice were generated that
express ChR2-H134R and tdTomato in dopaminergic neurons after activation by Slc6a3cre (Figures 4.4-5). Slc6a3-Cre+ mice (treatment groups) and Slc6a3-Cre- mice (no ChR2
expression, control groups) were implanted with optical fibers in the right ventral
tegmental area (VTA; coordinates AP: -3.44, L: 0.5, DV: -4.1) (Fig. 3.3.1). Phasic, burst
stimulation in this region is established to cause place preference (42,112). Mice were
conditioned over 3 days. The control and power modules were first connected and then
plugged into the optical module immediately prior to the conditioning sessions.
Stimulation (20 pulses, 20 Hz, 2-4 ms pulse width, 5-10 mA, 1 minute period) was
provided only in the afternoon. While input current controls the optical irradiance, the
optical dose is also dependent on the pulse width and is described as output energy per
pulse (optical power multiplied by the pulse width). The OGS was programmed to
achieve a specific range of doses (Figure 3.6a). At various irradiances, pulse widths from
1 to 1000 ms have been shown to elicit action potentials (8) and drive behavior
(38,42,112). We tested the ability to drive place preference with two groups (treatment
group 1, Tx1, lower dose range and 2, Tx2, higher dose range). Only the higher dose
range Tx2 showed a significant increase in change of preference (one-way ANOVA, F3,18
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= 13.3983, p = 0.00008, Tx2 significantly different to all other groups with TukeyKramer post-hoc, α = 0.01) and significantly greater post-test preference (F3,18 = 9.2681,
p = 0.0006, Tukey-Kramer post-hoc, α = 0.05) (Figure 3.6c, d). Critically, in treatment
groups, the post-test preference for the conditioned chamber increased with dose (Figure
3.6f), and activity levels were not significantly different between groups (F3,18 = 1.2971,
p = 0.3059) (Figure 3.6b) or between the pretest and post-test (Figure 3.7). These results
are consistent with previous tethered optogenetic CPP experiments (42,112).

Figure 3.4 Histological characterization of optical fiber implants. a) Optical fiber
placement at the right ventral tegmental area (VTA). The black arrow points to the VTA
(shaded blue) and the red circles show the placements of individual optical fibers. b)
histological characterization with c-fos staining for neurological activity after 1 hour of
the CPP stimulation protocol (20 Hz, 10 mA, 4 ms, 20 pulses per minute). The black
asterisk indicates the optical fiber lesion tract. Red box indicates the implant site (VTA).
Blue box indicates enlarged view in c. c) Enlarged view of blue box in b. White arrows
point to c-fos positive neurons indicating recent neural activity. Bar = 50 µm. d) Confocal
image of IBA1 (green) and tdTomato (red). As is typical for implantations, IBAI shows
mild microglial activation immediately adjacent to the fiber lesion tract (brighter green).
As expected following Slc6a3-cre activation, the tdTomato is localized at the VTA
(white arrow). White asterisk indicates fiber lesion. e) Enlarged view of white box in d
showing Slc6a3 activated tdTomato. For further histological characterization of B6.SJL-
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(CAG COP4*H134R/TdTomato); Slc6a3-cre mice, see Figure 3.5. Scale bars a,b 1mm; c,
250 µm; d, 200 µm; e, 500 µm.

Figure 3.5 Histological characterization of B6.SJL-(CAG
COP4*H134R/TdTomato);Slc6a3-cre mice. a) tdTomato (Red) expressed in axon tracts
(white asterisk). b) tdTomato expressed in soma (white arrows) and dendrites. c) DAT,
dopamine transporter, antibody labeling (green) in the VTA. d) Slc6a3-cre activated
tdTomato (red) in the VTA. This overlays with DAT in c to infer expression of ChR2H134R in dopamine producing neurons. Scale bars a = 100 µm; b = 50 µm; c, d = 200 µm.
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Figure 3.6 Dose dependent induction of conditioned place preference. a) Optical dose
range and mean for each group (n = 4-8 per group). b) Posttest activity. There was no
difference between groups (one-way ANOVA, F3,18 = 1.2971, p = 0.3059). c) Change
(posttest – pretest) in preference towards conditioned side. Tx2 preference change was
significantly different to all other groups (one-way ANOVA, F3,18 = 13.3983, p = 0.00008,
Tukey-Kramer post-hoc, α = 0.01). All other groups were not significantly different from
each other (TK post-hoc, α = 0.01 and 0.05). d) Posttest preference. Tx2 preference was
significantly different to all other groups (F3,18 = 9.2681, p = 0.0006, TK post-hoc, α =
0.01 for Ctrl1 and Tx1, α = 0.05 for Ctrl 2). All other groups were not significantly
different from each other (TK post-hoc, α = 0.01 and 0.05). e) Posttest preferences versus
optical dose for all control groups. Red open circles = Ctrl 1, blue open circles = Ctrl 2. f)
Posttest preferences versus optical dose for all treatment groups. Red closed circles = Tx
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1, blue closed circles = Tx 2. All error bars show standard errors unless indicated
otherwise. *Indicates significance across all groups.

Figure 3.7 CPP results. a) Boxplot of post-test activities in the CPP experiments. The
lower outlier in the Ctrl group (Ctrl 1) was excluded from analysis due to non-exploratory
behavior. b) Activity during the pretest (dark grey) and post-test (white). There was no
difference in activity between pretest and post-test for all groups (paired Student’s t-test).
c) Preference score for pretest (dark grey) and post-test (white). All error bars are
standard errors. For statistical analysis between groups, see Figure 3.6.

3.4

Discussion and Conclusion

The OGS is compatible with current behavioral assays in rodents. It offers user
defined stimulation protocols, controllable optical dosing, wireless triggering, and deep
brain targeting with a modular fiber-ferrule approach. To the author’s knowledge, this is

88
the first untethered optogenetic device to successfully drive behavior dependent on deep
brain structures with a fiber-coupled LED. Recently, Hashimoto et al. developed a novel,
battery-powered, multi-LED stimulator with wireless infrared control of stimulation
parameters (duration, frequency, and pulse width) (111). The device was demonstrated in
vivo with transcranial stimulation. For targeting intracranial structures, the authors
coupled a 0.5-1 mm diameter optical fiber and could produce 1.9 mW/mm2. This device
does not allow control of the optical power and is a relatively large optical fiber if it were
to be used in deep brain structures. Importantly, the OGS can control the optical dose by
programming the control module. With a 200 μm diameter fiber, an irradiance of 27
mW/mm2 (21.01 mA) is achieved. The modular OGS design allows for rapid
improvements and expansion. As a result, the device serves as a platform to integrate RF
circuitry (207) (Chapter 4) to recharge the solid-state batteries or replace them in fully
implantable implementations, incorporate an electrical stimulator, and add front-end
sensors (56,208), signal processing (28) for closed-loop experimental paradigms (85,115),
and aspects of other MCU based optical stimulators (40,111). Importantly, we used
commercially available components, so the OGS can be widely accessible. The schematic,
suggested PCB layout, fabrication, and basic code for the MCU are made available by
request. The future of novel, miniature devices, such as the OGS, is promising.
Technological advances paired with the proper molecular tools enable new experimental
designs in modern neuroscience research and have far reaching implications for the study
and treatment of diseases.
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3.5

Materials and Methods – Device Fabrication

The optogenetic stimulator (OGS) was designed and fabricated using a host of
equipment and software packages. The device layout for the printed circuit board (PCB)
was developed using Osmond PCB software. PCBs were fabricated in house with a
milling machine (ProtoMat S100, LPKF, Tualatin, Oregon, USA or Accurate 350,
Accurate CNC, Inc., Fort Wayne, IN, USA). All PCBs were populated with components
using a combination of reflow and hand soldering. Populated PCBs were cleaned with
acetone and then isopropyl alcohol or methanol.

3.5.1

Optical Module

The optical module was fabricated on FR4 printed circuit boards (59 mil thickness,
106394-1, LPKF). Two different sized through holes were drilled into the board to mount
the ferrule and LED. From the topside of the board, with a 1.20 mm diameter drill bit
(hole ~1.25 mm), the first through hole was made. From the same side, with a 2.00 mm
diameter drill bit, the second through hold was made halfway through the board. Due to
process variations, the 2.00 mm diameter hole may not always be deep enough and this
can be corrected by manually extending the through hole with the drill bit. 1.25 mm
diameter zirconia ferrules (Thorlabs) were cut with a diamond-crusted dremel blade, and
stripped 200 um diameter optical fibers were inserted into the shortened ferrule and
sealed with epoxy. The fiber-ferrule was then polished using previously described
protocols. First, a low insertion force connector (CLE-105-01-G-DV, Samtec, New
Albany, IN) was populated. Then the LED (PointLED, OSRAM, Munich, Germany) was
reverse mounted from the top side of the PCB, and the fiber-ferrule was then inserted
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from the bottom side. Medical grade epoxy was used to add mechanical stability to the
ferrule-PCB connection. A diamond tipped pen was used to score and break the optical
fiber to the desired length. Variation in coupling efficiency of the optical module (Figure
3.3a) has potential to alter optical output for a given driving current. Low efficiency
modules required a higher input current to provide the same optical output as a high
efficiency module.

3.5.2

Control Module

The control module was fabricated on FR4 PCB (22 mil thickness, 108761, LPKF,
Garbsen, Germany). The topside was populated with the microcontroller (MCU,
LPC1104UK, NXP, Eindhoven, Netherlands; 2.2 mm x 2.3 mm) and constant current
driver (ZLED7012, ZMDI; 2 mm x 2 mm). Low insertion force connectors are used to
attach the optical and power modules. This architecture allows the design of low duty
cycle operation. Untethered devices benefit from carefully designed stimulus waveforms,
where the duty cycle is minimized without decreasing the desired modulation of neural
activity, in order to reduce power demands and increase lifetime of operation under a
given power budget (135). For example, when calculating with a safety factor of 2, the
duty cycle used during in vivo experimentation was less than 0.3%. The safety factor
doubles the calculated duty cycle. This provides a conservative estimate for design.
Wireless triggering is implemented by passively rectifying RF signals at 2.4 GHz (Figure
4.2). This is similar to a previous wireless stimulator design (42); however, power
demands are much less for our design since the rectified signal is only driving the trigger
which requires significantly less power. Importantly, the batteries and capacitors provide
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the necessary power to drive the LEDs. The RF power link calculations are detailed
below. When the wireless trigger is not needed, it can be removed.
The Friis transmission equation (209) (Equation 3.1) can be used to estimate the
power budget of a wirelessly powered RF system in the far field. Often, the log (base 10)
format (Equation 3.2) is preferred since simple addition and subtraction can be used.
Here we use the log form and report power values in dBm and antenna gain in dBi. The
equations are

$ λ '2
Pr = Pt G t &
) G
% 4 πR ( r

€

(3.1)

log(Pr ) = log(Pt )

$ λ '
) + log(G r )
% 4 πR (
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(3.2)

€ where, P = Power received at the input to the rectifier; P = Power transmitter from the
r
t

RF power amplifier into the transmit antenna; G t = Gain of the transmitting antenna; G r
€

€ (2.4 GHz = 0.125 m); R = distance
= Gain of the receiving antenna; λ = wavelength
€ (1 m).
from transmit antenna to receive antenna

€

€ at the input of the rectifier (1 meter distance)
€
The power required
is determined by
power required at the comparator input and the efficiency of the rectifier. The input
power to the comparator is given by:
P = IVload =

€

2
Vload
Rload

(3.3)
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where, P = Power; I = Current; Vload = Voltage across the load (input to the
comparator); Rload = Resistance of the load. The threshold voltage is 0.2 V and the load is

€ 1 MOhm; therefore,
€
€ power is 43.98 dBm (40 nW). In actuality, slightly less
the input
€ will be required since the bias current into the comparator is 10 nA
power

(www.maximintegrated.com/datasheet/index.mvp/id/5823). This creates a 0.01 V offset.
Assuming a conservatively low rectifier efficiency of 25% (-6 dBm), the required power
received at the input to the rectifier is -37.98 dBm (160 nW). Equation 2 can be
rearranged to solve for the required power transmitted (log(Pt) + log(Gt)). Assuming a
receiving antenna gain of -10 dBi, the required transmitted power is 12.07 dBm, well
below the Federal Communications Commission (FCC) maximum effective isotropically
radiated power (EIRP) of 36 dBm (4 W) for ISM bands (FCC, Part 15—Radio frequency
devices, Title 47, CFR 15; http://www.ecfr.gov/). There is a nearly a 24 dBm (251.1 mW)
buffer to account for other mismatches.

3.5.3

Power Module

The power module was fabricated on 22 mil thick FR4 PCBs. Surface mount
(QFN package, 8 mm x 8 mm) or bare dies (5.7 mm x 6.1 mm) of the solid-state batteries
(CBC050, Cymbet, Elk River, MN) were used (Figure 3.1-2). For the surface mount
batteries, each battery was soldered to a PCB. Two battery-mounted PCBs were then
physically stacked and connected. Mechanical stabilization was achieved by threading
through holes with wires. Company specified battery-handling instructions were followed
(www.cymbet.com, AN-1026).
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The die battery module consisted of more complex fabrication procedures. First
the pads of the bare dies were stud bumped with a wire bonder. One gold wire bond was
made to each pad of the battery. The floating tails (non-bonded end) were manually
removed with forceps under a microscope. Conductive epoxy was applied to each of the
stud bumped pads and allowed to cure for an hour at 75 oC. Conductive epoxy was then
placed on the battery footprint pads of the PCBs and the bare dies were flipped, attached,
and allowed to cure for an hour at 75 oC. Two batteries were then stacked with a process
similar to the surface mount battery modules.
To provide the needed current for stimulation, a 1 mF tantalum capacitor was
mounted on a separate PCB (22 mil) and connected in parallel to the batteries. To provide
larger values of current, supercapacitors or ultracapacitors may be used as well (Figure
3.2a). When using a tantalum capacitor, it is important to consider the leakage current.
Carefully selecting the capacitor and using voltage ratings higher than needed (derating)
can minimize leakage and also protect against failures due to transient overvoltages.
Capacitor sizing for the batteries is detailed in Cymbet application note AN-1025.
Maximum, minimum, and recharge voltages for stimulation were 4.0, 3.0, and 4.1 V,
respectively. Briefly, the designer must decide the capacitance value and then determine
if there is sufficient recharge time with the intended power source. Importantly, there is a
tradeoff between capacitance size and recharge time (Figure 3.2f) that must be considered
in order to apply a stimulation protocol. This powering strategy should be used in low
duty cycle applications. For more stringent and power demanding experiments, such as a
continuous sine wave of stimulation, higher power sources should be used. One possible
source is the 10 mA-hr battery used by Hashimoto et al. (111).
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3.5.4

Device Programming

The microcontroller (MCU) algorithm was created with CrossWorks for ARM 2.2
(Rowley Associates, Dursley, United Kingdom), a C/C++ development environment. A
custom development board was designed and fabricated to allow debug and program
download through a 10-pin serial wire debug (SWD) interface. Current, timing, device
verification, and power consumption measurements were taken using this development
board. Example code specific to this device is made available upon request to any
interested external users for looping stimulation protocols.

3.5.5

Optical Measurements

Optical power was measured using a triple power supply (Agilent 3631A; Agilent,
Santa Clara, CA), digital multimeter (DMM, Agilent 34410A), optical power meter
(PM100D, Thorlabs, Newton, NJ) and sensor (S121C, Thorlabs). The power supply was
connected in series to the DMM and optical module. A threaded-fiber adaptor (S120-FC,
Thorlabs) was connected to the S121C sensor to prevent non-fiber emitted light from
entering. The optical module was stabilized on a stand and the fiber was placed next to
the sensor through the FC/PC hole. The power meter was set to “Relative Power” to
subtract the ambient light. For blue light, the wavelength, λ, was set to 473 nm. Optical
power data points were collected from input currents of 0 – 25 mA. To measure
frequency and pulse width data, the development board was used with an uncoupled LED.
The PM100D bandwidth was set to “HI” and the analog voltage output was recorded with
a 350 MHz oscilloscope (MSO7034B). Since this data is not calibrated by the PM100D
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and only timing information was desired, normalized values were reported. The data was
normalized by the maximum analog output at a specific current input.

3.5.6

Temperature Measurements

Post euthanasia, devices with dental cement intact were removed from the skull
and 2-wire thermistors were superglued to the ventral surface of the optical module. The
thermistors were placed adjacent to the optical fiber and the 2-wires were connected to a
digital multimeter (DMM; Agilent 34410a) with temperature sensing functionality. The
optical module was controlled with a custom LED driver circuit board, waveform
generator (Agilent 33522a), triple power supply (Agilent 3631A), and a DMM. The
DMM was programmed to sample at 1 Hz for 8 minutes while the optical module was
OFF for 1 minute, ON for 3 minutes, and then OFF for 4 minutes. The input current and
frequency of stimulation were varied while the pulse width was held at 10 ms. The
current was varied at 5, 10, and 20 mA while the frequency was 20 Hz. The frequency
was varied at 10, 20, and 30 Hz when the current was held constant. All measurements
were taken at room temperature (22 – 24 oC).

3.6

Materials and Methods – in vivo Validation

For the condition place preference (CPP) experiments, B6.SJL-(CAG
COP4*H134R/TdTomato);Slc6a3-cre mice (Slc6a3-Cre) were generated by mating
B6.(ROSA)26Sor<tm27.1(CAG-COP4*H134R/tdTomato)> and B6.SJLSlc6a3tm1.1(cre)Bkmn/J mice. In Cre+ mice, the channelrhodopsin:TdTomato cassette is
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selectively expressed in dopaminergic neurons. Adult Cre+ and Cre- mice (22-35 g) were
selected for experimental and control groups, respectively.

3.6.1

Animal Surgery

Mice were anaesthetized in an induction chamber (5% isoflurane) and then
prepped for surgery. The mice were secured in a stereotaxic frame (1-2% isoflurane) and
given carprofen (IP, 5 mg/kg). After the initial incision, connective tissue was removed
until the skull was exposed. A craniotomy was made above the right ventral tegmental
area (VTA, AP -3.44, L 0.5). The dura matter was removed and optical fiber was
implanted to the VTA (AP, -3.44, L 0.5, DV: -4.1) Coordinates were selected from
previous studies(112) and confirmed with the Paxinos mouse atlas (210). Coordinates
were adjusted for undersized mice, and a custom stereotactic adaptor was made to hold
the optical module. After implantation, the optical module was secured with dental
cement (Liquid Denton, Pentron). Mice were given a SQ bolus of warmed sterile saline
and allowed to recover for at least 3 full days prior to behavioral testing. The Jackson
Laboratory IACUC approved all procedures and protocols (#99108).

3.6.2 Conditioned Place Preference
A randomized 3-chamber CPP procedure was performed over 5 days similarly to
previously published protocols (42,112,206). Randomization refers to the chamber
assignment for the unconditioned stimulus (discussed below). Two identical unbiased
commercial 3-chamber CPP behavioral apparatuses were used (Med Associates, St.
Albans, VT). The middle chamber had grey walls with a solid floor while the two side
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chambers had a black wall with solid bar flooring and a white wall with mesh grid
flooring. On the morning of day 1, the pretest was performed. Mice were given 5 minutes
to habituate in the middle chamber and then 15 minutes to explore. For days 2-4, mice
were given two 30-minute conditioning sessions, one in the morning and one in the
afternoon. Conditioning sessions were at least 4 hours apart. For all morning sessions,
devices were attached but no stimulation was provided. During the afternoon session,
devices were attached and stimulation (20 Hz for 1 second every 60 seconds, 2-4 ms
pulse width, 5-10 mA input current) was provided. On the morning of day 5, the posttest
was performed identical to the pretest.
After the pretest, a preference score for the black chamber was made for each
subject. Based on this preference, we randomized the chamber in which each subject
would always receive optical stimulation (afternoon conditioning session). If any subject
had a pretest preference of greater than 80% or less than 20%, they were removed from
the study.

3.6.3 Immunohistochemistry
For fluorescent immunohistochemistry, brains were placed into ice-cold 4% PFA
for 24 hours followed by 30% sucrose overnight; frozen in OCT compound and
cryosectioned at a thickness of 20µm. For immunohistochemical staining, the techniques
outlined in the literature (211) were followed with a few alterations. Briefly; slide
mounted sections were allowed to warm to room temperature (RT) in a desiccating
chamber for 30 minutes and then washed with 5% Triton-X in phosphate buffer (PBST)
for 5 minutes. Following this sections were incubated for 2 hours at RT with antibodies
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against GFAP, IBA1 or DAT (all Abcam, USA) in 0.5% BSA and 10% chick serum in
PBST. Sections were then washed 3 times in PBST for 5 minutes each and incubated
with either chicken or rabbit secondary antibodies conjugated to AF488 (Invitrogen, USA)
in 0.2% BSA in PBST for 1 hour. Finally sections were washed 3 times for 10 minutes in
PBST, incubated with DAPI in PBS for 5 minutes, washed again for 5 minutes with
PBST, mounted in Fluoromount, coverslipped, and sealed with nail polish.
For cFos staining a Ventana Discovery XT was used with anti-cFos (Abcam,
Cambridge, MA). The detection kit was a ChromoMap DAB, a multimer-based HRP kit
(Ventana Medical Systems, Tucson, AZ) using an anti-rabbit secondary (OmniMap antirabbit HRP).
For Nissl staining and hematoxylin and eosin (H&E) staining, mice were
euthanized by perfusion fixation with ice cold PBS followed by ice cold 4% PFA,
embedded in paraffin and serially sectioned to 5µm thick. Sections were deparaffinised
with two 5 minute washes in xylene and rehydrated through a graded alcohol
concentration (100%, 95%, 70%). For Nissl staining sections were incubated at 60°C in
warm filtered cresyl violet solution for 8 minutes. H&E staining sections were incubated
in hematoxylin for 4 minutes and washed in water for 5 minutes before being blued in
ammonia water for 1 minute. Slides were differentiated in two changes of 95% alcohol
before dehydration in 100% alcohol and cleared with xylene. Slides were mounted with
Permount, coverslipped and sealed with nail polish.
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3.6.4

Experimental Design

For CPP, 4 groups were tested: Control 1 (Ctrl 1, n = 4), Control 2 (Ctrl 2, n = 4),
Treatment 1 (Tx 1, n = 8), and Treatment 2 (Tx 2, n = 6). Optical dose per pulse was
controlled and determined by multiplying the optical power output by the pulse width
(PW) as given by:

Doseoptical = Poweroptical × PW

.

(3.4)

€The power output for a given optical module at a specific current input is dependent upon

the optical efficiency of the LED and coupling efficiency between the fiber-ferrule and
LED. The optical efficiency of the LED varies with each batch from the manufacturer
and end users are not provided with information. According to the PointLED data sheet,
there are four bins of LEDs and the manufacturer does not sort them. Due to this
uncontrolled factor and variability in fabrication, optical modules will have some
variance in optical power output for a given current input. This variance accounts for the
range in optical doses for each group.
Previous studies have shown ChR2 to be activated in vivo with pulse widths as
short as 1 ms (38). To demonstrate the capacity of the device to titrate optical doses, we
first controlled for pulse width (2 ms) and varied the input current for groups Ctrl 1 and
Tx 1. The input currents proportionally reflected the irradiance per pulse. Either 5 or 10
mA driving currents were used to deliver the optical doses. There was no behavioral
difference between groups, and we believed this was a result of insufficient optical dose.
We then hypothesized a higher optical dose would could result in place preference. For
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Tx 2 and Ctrl 2, doses were increased by implanting more efficient optical modules and
ranging pulse widths from 2-4 ms.
One mouse from Ctrl 1 was excluded from the data analysis due to nonexploratory behavior during the posttest. The subject’s activity levels were ruled as low
outliers when grouped with all controls and all mice (Figure 3.7). Another subject
replaced this control. One mouse participated in both Tx 1 and Tx 2. In Tx 1, this mouse
had less than a 0.03 change in preference. When participating in Tx 2, this mouse
performed another pretest and was then conditioned with light on the opposite chamber
as in Tx 1. Other mice with less than a 0.05 change in preference from Tx 1 were tested
as well with increasing dose; however, an unexpected disturbance occurred during testing
and all of those subjects were removed from the study.

3.7

Preference Scoring and Statistical Methods

After the pretest, the pretest preference for the black chamber was calculated as:

Pblack =

t black
t black + t white

(3.5)

€ where, P = preference score and t = time for the respective chambers. The distribution
of pretest preferences was plotted in a histogram to determine if the 3-chamber apparatus
€

€
bias existed. Posttest preference
scores were calculated similarly:
Pc =

€

tc
t black + t white

(3.6)

101
where P = preference score, t = time, and c = black or white. To obtain the change in
preference, the preference scores from the posttest for the chamber paired to the optical
€

€
stimulation was subtracted
from pretest preference score for the same chamber. This is
given by:
(3.7)

ΔP = Pposttest,c − Ppretest,c

€ To determine if there was a significant difference in ΔP between means from all groups,

an one-way ANOVA for unbalanced groups was performed. A Tukey-Kramer (α = 0.01
and 0.05) post-hoc analysis was conducted for multiple comparisons. P < 0.05 was used
for significance. Pretest and posttest activity scores were compared with a paired
Students t-test (Figure 3.7). For comparisons between groups, see Figure 3.6 in the main
text. Statistical analyses were made in MATLAB (R2010a; MathWorks, Natick, MA) and
STATA 10 (StataCorp, College Station, TX).

3.7.1

Optical Power Analysis

A least squares linear regression in Microsoft Excel was performed on the raw
data to predict the optical power output for a given current input. Since input currents
were typically 5-10 mA, the regression was not forced to cross the y-axis at zero in order
to minimize bias for lower current data points. Descriptive statistical analysis was
performed on the slopes and y-intercepts. The mean, 95% confidence intervals and range
were calculated in MATLAB.
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3.7.2

Temperature Analysis

The ambient temperature, determined by the first minute and last minute of recording,
was subtracted from the raw data to obtain the change in temperature due to stimulation.
The maximum value from the 3 minutes of stimulation was selected. Five devices were
tested and the average maximal change under each set of stimulation parameters was
reported. Analysis was performed in Microsoft Excel.
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CHAPTER 4. THREE AXIS RCFET WIRELESS POWERING CAGE

Wireless powering of implantable medical devices is a foundational engineering
challenge in freely behaving animals. Current rodent behavioral studies are dominated by
wired technologies which are physically restrictive, susceptible to infection from the
percutaneous connector, and impractical for large scale, chronic experimentation.
Batteries are popular with clinical devices; however, the weight, size, and lifetime limit
the applications. Wireless powering technology would obviate the aforementioned
disadvantages and eliminate the need for batteries. The solution must deliver sufficient
power to the load while minimizing harmful biological tissue interactions and noise to the
acquisition system. This work will use the principles of strongly coupled magnetic
resonance (SCMR) for planted radiofrequency (RF) powering as a solution (136).
To design a magnetic resonance powering system for biomedical applications
requires a robust understanding of the relationship between physical design, circuit
models, and optimization equations. Previously, others have experimentally demonstrated
powering to multiple receivers (138,146), control of impedance parameters or transmit
frequency to maximize power transfer with respect to distance (144,212), and powering
of a left ventricular assist device (LAD) ex vivo (139). Recently, much work has been
performed using microwave filter design methods, specifically the use of impedance
inverters (142,144-146). BPF synthesis greatly simplifies the design methodology. As
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such, this work will use microwave bandpass filter (BPF) synthesis techniques to design,
model, and realize the physical powering solution (144,146,213-215). In particular, the
resonantly coupled filter energy transfer (RCFET) method developed by Mei et al. is used
to design the WPT system (147). Section 4.1 will introduce basic concepts important to
BPF WPT systems. Section 4.2 will detail basic BPF design equations. Section 4.3
arrives at an impedance match condition with respect to the characteristic impedance of
K-inverters. While the impedance match condition is not novel, to the author’s
knowledge, the specific equation has not been shown in literature. Section 4.4 discusses
the RCFET method and validates the design solution against the impedance match
equation in Section 4.3. The RCFET method should arrive at the same impedance match
solution for maximal WPT. Detailed RCFET equations will not be presented as the work
is currently unpublished and is the intellectual contribution of Mei et al. (147). Section
4.5 presents the novel design of the three-axis RCFET wireless powering cage and
preliminary in vivo results. Future work will be to more extensively validate the cage in
vivo. Novel contributions in this chapter are as follows:
1)

Derivation of the optimal impedance match condition with respect to
the characteristic impedance of impedance inverters (K-inverters)

2)

Design of the three-axis RCFET wireless powering cage

3)

Preliminary in vivo validation of the cage
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4.1

Basic Concepts in Bandpass Filter Wireless Power Transfer Design
4.1.1

Description of Resonantly Coupled Systems

The first demonstration of magnetic resonance coupling used 4 coils—2 loops and
2 resonators (Figure 4.1) (136). The first loop is connected to the powering source and
inductively coupled to one resonator. In a mirroring fashion, the second loop is connected
to the load and inductively coupled to the other resonator. The two resonators are
resonantly coupled.

Figure 4.1 Four coil strong magnetic resonance powering configuration. Mi,j = mutual
inductance between coils i and j. ki,j = coupling coefficient between coils i and j. Cross
coupling between L0 and L2, L0 and L3, and L1 and L3 are 0 and not shown in the figure.
Z1 = the impedance seen by the source.

The electromagnetic energy exchange between two coils (i and j) is described by the
coupling coefficient, ki,j (142). Coupling is primarily a function of geometry and physical
positioning of the powering coils (216). For instance, as two axially aligned coils are
separated farther apart or misaligned, the coupling coefficient decreases. The other
crucial physical parameter in inductive and magnetic resonant systems is the quality
factor, Q, of the coils. The quality factor is the ratio of the energy stored to energy
dissipated. In coils, Q can be related to the inductance, L, and series resistance, R, at the
resonant angular frequency, wo, by (Equation 4.1) (216).
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Q≈

w0L
R

(4.1)

Q and k are the two most import physical factors in maximizing power transfer and are

€ often described as the multiplied entity, kQ (217,218). As k is defined by the physical
powering setup, much research has been placed on coil design to maximize Q (218,219).
Low kQ systems will limit the maximal power transfer efficiency.
In Figure 4.1, the coupling coefficients k0,1 and k2,3, are known as external
coupling coefficients. These terms describe the relationship between a load or individual
input and output ports with the nearby internal resonator. Mi,j represents the mutual
inductance between coils i and j and describes the rate of magnetic flux change in coil j
with respect to the rate of current change in coil i. Similar to the coupling coefficient, the
mutual inductance is only dependent on the geometry of the coils. The relationship
between ki,j and Mi,j is (213):
ki, j =

M i, j
Li L j

(4.2)

€ The mutual inductance between coils directly affects the impedance parameters of the

circuit. The impedance seen by coil 1 due to coil 2 is equal to (212):

Z1,2 = −iωM1,2

(4.3)

where i = (-1)1/2 and ω is the angular frequency.

€ Maximum power transfer between a source and load is observed when the source and
load impedances are equal (purely resistive) or conjugately matched (reactive
components). One method to meet this impedance match condition is to solve for all the
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currents in each unique branch of the circuit (136,212,220). This results in a set of
lengthy and complex equations as the number of coils increases. To physically realize the
model, the coupling coefficient, k1,2, between the two resonators can be determined first
by measuring the mutual inductance for a specific distance and orientation. Then the
external coupling coefficients can be tuned to meet the impedance condition. Tuning is
achieved by rotating or increasing the distance of L0 with respect to L1 or L3 with
respect to L2 (136,143). Defining the optimal impedance condition, desired coupling
coefficient between resonators, and tuning external coupling coefficients are the critical
steps in designing WPT systems for maximum power transfer.

4.1.2

Maximal Power Transfer with BPF Design Methods

BPF synthesis is a well-developed field that has been traditionally used for
telecommunications (214,220). Using BPF for WPT is different to telecommunications in
two respects (146). Firstly, in WPT system for biomedical applications, the physical
system is defined by the end experiment. Then the optimal filter parameters are solved
for. In telecommunications, the desired filter parameters are defined first and then the
physical solution is realized. Secondly, all the traditional BPF parameters are not critical
for optimal performance in WPT. The filter response should be maximally flat; simple
Butterworth filters are typically used. The physical power transfer system of Kurs et al.
(136) can be viewed as a BPF model (215) (Figure 4.2). This equivalent circuit has 3
primary advantages: 1) a direct-coupled resonator is realized which results in the use of
only 2 coils for power transfer, 2) with lumped components, the BPF circuit is easily
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implemented on miniature circuit boards, and 3) the optimization of power transfer is
greatly simplified.

Figure 4.2 Bandpass filter representation of the four coil physical model in Figure 4.1.
The coupling coefficients between coils can be modeled as impedance inverters, Ki,i+1.
The external K-inverters are tunable (blue) while the impedance inverter, K1,2, is defined
by the geometric structure of L1, L2 and the distance between them. ZL is the load
impedance. Z1 is the impedance looking into K-inverter K2,3. Z2 is the impedance looking
into K1,2, and Z1 is the impedance looking into K0,1. C1 and C2 are capacitor values
forming resonators with L1 and L2, respectively. Coils are assumed to be of low loss. If
coils have high loss, a series resistance should be inserted at each coil. Rs is the source
resistance and Vs is the AC voltage source.
The mutual inductance between coils can be transformed or represented by
immittance (impedance, K, and admittance, J) inverters (142,213). The immitance
inverters invert the impedance or admittance seen by the port of analysis (Equation 4.4,
Figure 4.3). Previously, both K and J inverters have been used in BPF design of wireless
powering (142-145). K and J inverters are reciprocally related and are more convenient
when dealing with series and parallel resonators, respectively (213). In this work, K
inverters will be used. Ki,i+1 denotes the characteristic impedance of the K-inverter
between coil i and coil i + 1. For external couplings, the K-inverter represents the
characteristic impedance between the source or load and the adjacent coil.
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Figure 4.3 K-inverter impedance inversion. Ki,i+1 can be viewed as a two port network.
The K-inverter inverts the output load impedance, ZL, as seen at the input, Zin.

Z in =

2
K i,i+1
ZL

(4.4)

Maximal power transfer is achieved when the BPF has the lowest insertion loss. This

€ occurs when the proper impedance match condition between the source and load is
reached. BPF WPT design methodologies attempt to arrive at either the proper
impedance matching conditions (144-146) or minimizing insertion loss (147). Typical
behaviors of a resonantly coupled power transfer system are shown in Figure 4.4. Three
distinct power transfer regions are observed with two coupled resonators: over-coupled,
critically coupled, and under-coupled (Figure 4.4a). Over-coupling provides good power
transfer but splitting of the resonant frequency occurs (136,212). The frequency split
widens as the coupling coefficient nears 1. Power transfer is now optimal at two different
frequencies for a particular coupling coefficient, and power transfer at the resonant
frequency is suboptimal. The critically coupled point provides maximal power transfer
without frequency splitting, and the under-coupled region provides lower power transfer.
The coupling decreases proportionally to cubic distance between the coils (143).
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Figure 4.4 Power transfer behavior of two coupled resonators. The dotted line indicates
where the critical coupling point. This is where maximum power transfer is achieved at a
single frequency. k12 is the coupling coefficient. PTE = power transfer efficiency. *** =
undercoupled region and is typically where biomedical devices operate.
Most previous WPT systems have performed in the critical to strongly coupled regions
due to the high power transfer efficiencies (136,212,215). This cannot always be realized,
however. The general behavior of Figure 4.4 should be observed with any two-resonator
power transfer system given that the Q’s are infinite. In implantable biomedical systems,
though, Q’s are typically low due to the size of the receive coil. For instance, Harrison
used receive coils with a Q less than 10 (131), and Jow et al. have designed planar spiral
coils with Q’s less than 90 (219). As Q decreases, the maximal achievable optimal PTE
also decreases. Interestingly, at some low Q threshold, a given power transfer system no
longer exhibits the critical or over coupling behavior seen in Figure 4.4 (147). This is the
case for implantable biomedical systems as Q’s of small coils are far from ideal. As in
traditional inductive powering topologies, wireless power transfer design is thus limited
to the undercoupled region. Traditional inductive coupling techniques, though, load the
coils which further decrease the Q (138). Different to traditional inductive powering, K-
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inverters do not load the resonant coils and creates the proper impedance match to
achieve higher PTE’s. The WPT system in this chapter is designed to operate in the
undercoupled region but is able to maintain sufficient power transfer due to optimized
impedance matching.

4.2

Design Equations

Filter synthesis theory begins with a low pass prototype model that is transformed
to the desired filter type (213,214,220). A maximally flat, Butterworth filter response is
used throughout this work. From the prototypical element values of the desired filter
response, the relationship between mutual inductance and the characteristic impedance
can be found. Equations 4.5-11 show the relationships for the BPF in Figure 4.2 (213).
M i, j =

1
gi g j

(4.5)

K 0,1 = M 0,1 RsL1w 0 FBW

(4.6)

K1,2 = M1,2 w 0 FBW L1L2

(4.7)

K 2,3 = M 2,3 Z L L3 w 0 FBW

(4.8)

w 0 = 2πf 0

(4.9)

€

€
€
€
€

€
€

g0 = g3 = 2

(4.10)

g1 = g2 = 1

(4.11)

where FBW = fractional bandwidth, f0 = resonant frequency, w0 = resonant angular
frequency. The element values are specific to the maximally flat filter response and
others can be found in tables from microwave filter textbooks (213). From Equations 4.2
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and 4.6-8, the relationship between coupling coefficient and the characteristic impedance
of K-inverters can be easily determined. K-inverters can be physically realized by several
circuit topologies and many options can be found in Matthieu et al (213). In this work, a
2 capacitor network is used to represent the external couplings (Figure 4.5).

Figure 4.5 The physical realization of the external K-inverters, K0,1 and K2,3. Cs and Cp
are series and parallel capacitors, respectively. ZL is the load impedance and Zin is the
input impedance of the K-inverter.

Figure 4.6 Physical implementation of the bandpass filter. The external coils are replaced
by K0,1 and K2,3. K1,2, is defined by the geometrical properties of L1 and L2. C1 and C2
form a resonant structure with L1 and L2, respectively. C1 and C2 can be absorbed by Cs1
and Cs2, respectively, to reduce components. ZL is the load impedance. Rs is the source
resistance. Vs is the AC source voltage. Compare to Figure 4.1 and Figure 4.2.

The resulting physical manifestation of the BPF is shown in Figure 4.6. Assuming ZL is
purely resistive, the relationship between the capacitors and the characteristic impedances
of the K-inverters are (147,213):
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2
Rs2 − K 0,1

C p1 =

€

€

€

€

w 0K 0,1Rs

2
1+ w 02C p1
Rs2
Cs1 = −
w 0K 0,1Rs

Cp2 =

Cs2 = −

(4.12)

(4.13)

2
Z L2 − K 2,3

w 0K 2,3 Z L

(4.14)

1+ w 02C p2 2 Z L2
w 0K 0,1Z L

(4.15)

The values of C1 and C2 are determined by the desired resonant frequency, f0 (equations
4.16-17), and can be absorbed by Cs1 and Cs2, respectively for physical implementation.

€

€

f0 =

1
2π L1C1

(4.16)

f0 =

1
2π L2C2

(4.17)

From the previous equations, the physical realization of K-inverters allows the direct
tuning of the external coupling coefficients by 2 capacitor values. Additionally, it
removes the need for inductors L0 and L3 (Figure 4.1 versus Figure 4.6). Deriving the
impedance match condition will inform how the capacitors should be tuned.
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4.3

K-inverter Impedance Match Condition for a 2 Resonator BPF

The impedance matching condition of resistive loads for maximum power transfer
occurs when Z1 = Rs. Previously, Lee et al., demonstrated this condition for J-inverters
(144). A similar analysis can be applied to K-inverters. For a 2 resonator BPF (Figure
4.2), the impedance matching condition for the BPF is determined in Equations 4.18-4.23.
In this analysis, it is assumed that the coils are lossless (high quality factor).

€

€

€

Z3 =

2
K 2,3
ZL

(4.18)

Z2 =

2
K1,2
K2 Z
= 1,22 L
Z3
K 2,3

(4.19)

2
2
2
K 0,1
K 0,1
K 2,3
Z1 =
= 2
Z2
K1,2 Z L

Z1 = Rs =

2
2
K 0,1
K 2,3
2
K1,2
ZL

K1,2 Z L Rs = K 0,1K 2,3

(4.20)

(4.21)
(4.22)

€

€ Assuming a 50 ohm source and load, the matching condition is Equation 4.23.

K1,2 50 = K 0,1K 2,3

(4.23)

€ The process to design a BPF wireless powering system using the impedance match
condition is as follows. First, M1,2, L1, and L2 are measured with a vector network
analyzer at the resonant frequency. K1,2 can then be determined. K0,1 and K2,3 are
arbitrarily chosen to satisfy Equation 4.23. The capacitor values are determined by
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Equations 4.12-4.15. For low Q power transfer systems, the series resistance of each coil
would need to be added to the circuit model and equations. The high Q impedance match
condition (Equation 4.23) is used in Section 4.4 to validate the RCFET design
methodology.

4.4

RCFET Methodology

The RCFET design methodology developed by Mei et al. optimizes the BPF for
minimal insertion loss (147). The design method is unique in 2 respects: 1) the method
arrives at the minimal insertion loss criteria using the measured coil properties of
inductance, quality factor, and mutual inductance, and 2) K-inverter realization of the
capacitor values is not arbitrary. Previous methods in BPF synthesis optimize by only
measuring L and k and then arbitrarily choosing characteristic impedances to arrive at the
impedance match condition (144,146,215). As k and Q are both critical factors in PTE,
this difference allows the designer to predict the power seen by the load in simulation and
also realize realistic capacitor values for the K-inverters without several design iterations.
The RCFET design method is as follows: 1) measure coil properties and coupling
coefficient range between coils, 2) define a targeted critical coupling point to optimize for,
3) calculate the optimal mutual inductances 4) calculate the characteristic impedances
and 5) determine the K-inverter capacitor values. A comparison to previous design
methods is shown in Figure 4.7.
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Figure 4.7 Design process of BPF wireless powering systems. The left flow chart
calculates capacitor values by arbitrarily choosing characteristic impedance values for
K0,1 and K2,3 to satisfy equation 4.23. The RCFET design method is shown on the right
column.

As the design equations of the RCFET are unpublished, they will not be provided here.
Instead, simulations and physical measurements are used to validate against the derived
K-inverter impedance match condition. To demonstrate the RCFET methodology, a 2
resonator BPF design example is shown. Measured quantities including L1, L2, Q1, and Q2
can be found in Table 4.1. Figure 4.8 displays how the coupling coefficient changes with
respect to distance for coils L1 and L2. The target critical coupling point critical is chosen
to be equal to 0.03. To validate the RCFET derived capacitor values, the impedance
match condition from Equation 4.23 is first verified and the values are reported in Table
4.1. The values are in good agreement. The slight mismatch is due to finite Q, which is
not accounted for in Equation 4.23. RCFET, however, does account for coil losses. k1,2 is
approximately 0.03 at 11 cm (Figure 4.8) and the PTE was measured by the S21 response
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(Figure 4.9). Simulation (dotted black trace, Figure 4.9) and measurement (blue trace) are
in good agreement thereby validating the RCFET methodology.
Table 4.1 Two Resonator BPF Design Example
RCFET Input values
L1
805.7 nH

Calculated values
K0,1
9.0401

L2

805.8 nH

K1,2

0.8096

Q1

383.5

K2,3

4.5159

Q2

95.71

Cs1 || C1

2.438 nF

f0

3.998 MHz

Cp1

10.111 nF

FBW
Rs
ZL

0.04
50 Ω
50 Ω

Cs2 || C2
Cp2
K1,2 x 50
K0,1 x K2,3

3.188 nF
5.007 nF
30.3608
30.8175

Coupling coefficient vs distance
0.35
0.3
0.25

k12

0.2
0.15
0.1
0.05
0

0

5

10
distance, cm

15

20

Figure 4.8 Coupling coefficient, k1,2, for two resonator BPF design example. k1,2
decreases as the distance increases between coils L1 and L2. Coil parameters are found in
Table 4.1.
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BPF response, k12 critical = 0.03

−10

S21 power, dB

−20

−30

−40

−50

−60

−70

3

3.2

3.4

3.6

3.8

4
freq, MHz

4.2

4.4

4.6

4.8

Figure 4.9 Simulation and measurement of the PTE with respect to frequency. Power
transfer is nearly 0 dB at the critical coupling point. Refer to Table 4.1 for component
properties of the RCFET design example.

4.5

Three-axis RCFET powering cage

Wireless technology for freely behaving animal experiments require powering in
three spatial axes. The two resonator powering strategy is sufficient for experiments
where the subject is stationary (i.e. a virtual reality jet ball). Chronic, epilepsy related
experiments, though, need spatial freedom to study seizures and behavior. The
engineering objective is to design a powering system that would allow unrestricted rodent
housing and continuous powering. The proposed solution is a three-axis RCFET cage
(Figure 4.10). Coil 1 is the transmit coil and has magnetic, B, fields in the Z-axis. Coils
2a and 2b are relay coils with B fields in the X axis and Y axis, respectively.
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Figure 4.10. Three-axis RCFET wireless powering cage. Direction of magnetic fields, B,
produces are shown on the right. The cage dimensions are 12” x 12” x 11.5” (L x W x H).
The coils are made of 8 gauge copper wire. The top center wires are removable to
provide access for the subject. The receive coil is circular and 20 mm in diameter (not
pictured).
The cage design method is to 1) define acceptable coil sizes 2) sweep coil parameters for
high Q with respect to frequency 3) measure coil to coil coupling 4) determine optimal
capacitor values using RCFET and 4) verify simulations with measurements. This is
similar to the method in Figure 4.7. The cage is first characterized assuming a 50 ohm
source and 50 ohm load. This allows s-parameter measurements with the vector network
analyzer. Once the correct impedance matching conditions have been established, the
features of the power transfer frequency response are recreated for a complex, non-50
ohm load. In the case of powering a device, the load is a rectifier (AC to DC converter)
with storage capacitors and voltage regulation.
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According the NIH Guide for the Care and Use of Laboratory Animals, group
housing rats weighing 400-500 g require 60 in2/rat of floor space and 7 inches of height
(221). Often rats induced with seizures are singly housed and would require more floor
space. To allow ample of space, the powering system is designed to fit a separate 11 x 11
x 11 in3 housing unit. The powering system is built with a polycarbonate box. The
primary external source coil, coil 1, wraps around the box first. Then two other external
coils, coil 2a and 2b, are wrapped perpendicularly to coil 1 (Figure 4.10). Coil 2a and 2b
weakly couple to coil 1 and serve as relay coils to reorient the magnetic fields. Coils 1 –
2b are nearly the same size and have similar Q factor and inductance values (Table 4.2).
The Q is slightly lower for both coil 2a and 2b since both coils contain detachable wires
to allow entrance of the animal. The receive coil is small compared to the wrapped coils.
The diameter is 20 mm, and this size is tolerable by adult (260 g or larger) rats.
Decreasing the implantable coil size is an optimization that should be considered for
future iterations of the powering system.
Table 4.2 Coil Parameters for a Three-Axis RCFET Wireless Powering Cage

Measured Q
@ 4 MHz
Inductance L, nH
@ 4 MHz
Size and shape
Number of turns

Coil 1
(Transmit)
323.8

Coil 2a
(Relay)
262.5

Coil 2b
(Relay)
270.1

Coil 4
(Receive)
85

4252

4400

4325

346.9

12” edges
square

12.25” edges
square

12.5” edges
square

3

3

3

20 mm
diameter,
circular
3
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4.5.1 Magnetic Field Interactions
The three external coils allow energy to couple the receive coil in all orientations.
There are 2 general powering strategies to couple energy to the receive coil: 1) use each
external coil as an independent source coil 2) use one external coil as the source and the
other 2 coils as relays. Option 1 more simply realizes continuous powering through
theory as the case is simply 3 independent, 2 resonator BPF’s. Practical realization is
costly and disadvantageous, though. Multiple signal generators, phase shifters, and power
amplifiers would be required. Option 2 is theoretically more challenging, but
implementation requires only a single signal generator and power amplifier. Power is
transferred either directly from coil 1 to coil 3 or indirectly from coil 1 to relay (coil 2a,
coil2b) to coil 3. Option 2 is used due to cost and end user accessibility.
The interaction of magnetic fields from the drive coil and relay coils to the receive
coil must be considered for powering in various orientations. This conceptualization and
result is critical, as extensive coupling coefficient measurements would otherwise be
required with each cage iteration to observe the behavior. Current through coils 1, 2a, and
2b create alternating magnetic fields with component vectors in the Z, X and Y directions,
respectively. According to Faraday’s Law, the magnetic field from coil 1 induces an
electromotive force (emf) that is seen by both coils 2a and 2b. The emf pushes a current
through the relay coils, which then create magnetic fields. The emf is 90o out of phase
with respect to the coil 1 magnetic field (Figure 4.11). At resonance, the impedance is
real, and the induced current within the relay coils is in phase with the emf. Given these
conditions, the coil 2a magnetic field is always in phase with the coil 2b magnetic field.
For simplicity, the interaction between coil 2a and 2b is first considered. If both relay
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coils are coupling energy, using vector addition, the total magnetic field will oscillate in
amplitude in a singular direction throughout the entire XY plane (Figure 4.12). When the
receive coil is perpendicular to the total magnetic field vector, then the most amount of
power will be received as the induced currents due to the component magnetic vectors are
in the same direction and sum. When the receive coil is parallel to the total magnetic field
vector, then the least amount of power will be received. The induced currents due to the
magnetic vectors are in opposite directions and cancel. In this particular case, the receive
coil will see either maximal or no power at 45o (225o) and 135o (315o) with respect to
either relay coil. Coils 2a and 2b couple energy equally into the receive coil at these
orientations. Adding a Z component to the total vector does not influence the power
transfer when the receive coil is perpendicular to coil 1. To avoid the dead orientations
(no power transfer), coils 2a and 2b cannot be simultaneously coupling energy.

Figure 4.11 Phase of induced emf of relay coils 2a and 2b at resonance (4 MHz). The
magnetic flux, B, due to coil 1 induces an emf in coils 2a and 2b. When the slope of B is
0 (peaks and troughs), then the induced emf goes to 0. The resulting current in the relay
coils is in phase with the induced emf. The magnetic flux from coils 2a and 2b are then in
phase with each other and out of phase with coil 1. Amplitude is normalized.
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Figure 4.12 Power transfer when two external powering coils have in phase magnetic
fluxes. The receive coil (red) is shown in various orientations in one plane. B1 and B2
represent the magnetic flux orientation of two coils. The flux magnitude will follow the
sinusoidal pattern shown in Figure 4.11 (blue trace). B total is the sum of B1 and B2. The
direction of B total will become negative when B1 and B2 are both negative. Power is
maintained except in the second orientation from the left. The B1 and B2 components
will induce currents in opposite directions at the same time within the receive coil If the
currents are equal in magnitude, no power will be received. If there is a 90O phase
difference between B1 and B2, the currents in orientation 2 will still be opposite;
however, the time difference between the induced currents prevents cancellation.

The case of power transfer due to interactions between coil 1 and one relay coil (2a or 2b)
is more complex. The case will be considered for interactions between coil 1 and coil 2a.
The coil 1-coil 2b case should be nearly equal. The magnetic field between coil 1 and coil
2a is 90o out of phase since at resonance. The induced emf seen by coil 2a and resulting
current are in phase. The total magnetic field vector over one period of oscillation
generates vectors in every direction of the XZ plane. This should result in no power
transfer dead orientations when the receive coil is perpendicular to the plane. Some
orientations will have weaker power transfer than others, though, as the magnetic field
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from coil 1 is greater than coil 2a. The coil 1-coil 2b case is similar but with field
components in the YZ plane.
The results from the magnetic field interactions analysis provide the following
physical guidelines for the cage design: 1) coil 1 and a relay coil can provide power
transfer to a receive coil in all orientations perpendicular to the powering plane, and 2)
coils 2a and 2b cannot concurrently act as relays. The design solution is realized with
optical solid-state relays to switch the relay coils on and off (Table 4.3). When coil 2a is
acting as a relay, the terminals of coil 2b are shorted. When coil 2b is acting as a relay,
the terminals of coil 2a are shorted. This solution sets the physical conditions of cage.
The power transfer system can be modeled as a three resonator BPF with two operating
conditions.
Table 4.3 Operation of the Transmit and Relay Coils
Coil 1 (Tx)
Coil 2a (Relay)
Coil 2b (Relay)
4.5.2

Time Point 1
ON
ON
OFF

Time point 2
ON
OFF
ON

Three Resonator BPF and Impedance Match Condition

When compared to the 2 resonator BPF, the three resonator BPF model introduces
two K-inverter terms. Figure 4.13 is the model for a 3 resonator BPF. L1 is the
transmitting coil; L2n is the nth relay coil; L3 is the receive coil; Rs is the source resistance
(50 Ω); ZL is the load impedance; Z1-4, are the input impedances seen by the respective
K-inverters, Ki,j; Cm is the resonating capacitor for Lm; and Vs is an AC voltage.
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Figure 4.13 Three resonator BPF model of the three-axis powering cage. Orange Kinverters are set by the geometric relations of the coils L1, L2n, and L3. The blue Kinverters are tuned using a two capacitor topology. L1 is the transmit coil, L2n is relay coil
2a or 2b, L3 is the 20 mm diameter receive coil. ZL is the load impedance and Zi is the
input impedance of the Ki,i+1 inverter. Vs is the AC voltage source.
If it is assumed that the components are lossless, the source and load are real, and no
coupling exists between coil 1 and the receive coil, then the coupling coefficient between
coil 1 and 3 and K1,3 are 0. Under this condition, deriving the optimal impedance match
condition with respect to K-inverters is straightforward and follows the process from
Equations 4.18 – 4.23. When Z1 = Rs, then the relationship between characteristic
impedances is denoted by Equation 4.24.

K1,2K 3,4 = K 0,1K 2,3

€

(4.24)

When cross coupling between resonators (i.e. k1,3) cannot be ignored, then the impedance
match condition can be solved by using the impedance matrix. Lee et al., previously
provided the matching condition with J inverters for optimal power transfer in a BPF
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model with relay coils (145). As J inverters are reciprocal to K-inverters, this condition is
easily adapted to the K inverter case. The optimal power transfer is observed when:

[Z ]1,1−1 =

€

1
2R

(4.25)

where [Z] is the impedance matrix of the BPF, and R is the impedance value of the
source, Rs, and load, ZL, (assumed to be equal). The impedance matrix terminology for a
BPF can be found in standard microwave filter-engineering textbooks (213,214). Using
−1
Matlab, the [Z]1,1
term is shown in Equation 4.26.

€

€

2
K1,2n (K1,2n K 3,4
− 2K1,3K 2n,3 Rj)
[Z] =
2
2
2
2
R(K 0,1K 2n,3 + K1,2n K 3,4 − 2K1,3 RK1,2n K 2n,3 j)
−1
1,1

(4.26)

To verify that the RCFET method and this impedance match condition can arrive at the
same solution for a 3 coil BPF, a simulation is run with arbitrary coil parameters and
coupling coefficients (Table 4.3). High Q components are assumed, and the source and
−1
load are 50 ohms. The impedance match condition sets [Z]1,1
= 0.01. From Equation 4.26,
−1
the RCFET method arrives at [Z]1,1
= 0.0108 + i00261. These values are in good

€ becomes obvious as the number of
agreement. The advantage of the RCFET method
resonators used in a€BPF increases. Arbitrarily sweeping parameters to find usable
characteristic impedances for K0,1 and K3,4 to satisfy the impedance matrix derived
solution would be tedious and inefficient. Additionally, while the impedance match

127
condition can be determined for low Q coils used implantable biomedical applications,
the equations quickly complicate with increasing number of coils.
Table 4.4 Three resonator BPF design example
RCFET Input values
L1
6465 nH
L2
4098 nH
L3
400 nH
Q1
10000
Q2
10000
Q3
10000
f0
4.0 MHz
FBW
Rs
ZL

0.043
50 Ω
50 Ω

Calculated values
K0,1
6.49e5
K1,2
3.32e8
K2,3
2.75e7
K3,4
5.41e4
K1,3
2.02e8
1/2R
0.01
−1
0.0108-0.0026i
[Z]1,1

€

5.5.3 Coupling Coefficient Factors and Measurements
Defining the critical coupling coefficient to be used in the RCFET method
requires knowing the range of coupling coefficients between the receive coil and the
source or relay coil. Additionally, the general trends of coupling are important for design.
The coupling coefficient can change with respect to receive coil location and orientation.
To map the coupling coefficient trends with respect to location in the cage, the mutual
inductances at various locations within coil 1 are measured with a 2-port setup in with the
VNA (Figure 4.14). This method provides a faster technique to understand the general
trend of coupling, but the measurements are less accurate than a 1-port measurement
(213,214). These measurements are lower than the true coupling coefficient since the low
Q receive coil is further loaded. After understanding the general trends, a more accurate
range of coupling coefficients is later established through simulation in ADS and 1-port
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measurements. Coil 1 and the receive coil were aligned in a parallel fashion. The XZ
plane coupling map shows a saw tooth pattern for coupling. The greatest coupling occurs
near the coil wrappings and the smallest coupling is half way between two consecutive
coil turns (Figure 4.14a). The YZ plane has the same trend. The XY plane coupling map
shows that the coupling is greater on the ends and dips toward the middle (Figure 4.14b).
As the XY plane is moved along the Z axis, the same trend is observed. At Z = 6.5 cm
and 13.5 cm, though, instead of dipping towards the center, the coupling increases. This
shows that the worst coupling points are at the corners for 6.5 and 19.5 cm along the Z
axis. Away from the external coil edges, the coupling in the majority of the space is
homogeneous. As the receive coil orientation is rotated from parallel to perpendicular
with respect to coil 1, the coupling coefficient decreases and drops to 0 at 90o. These
general trends hold when the receive coil couples to any coil, source or relay.
Understanding the general trends in coupling, the locations with the maximum and
minimum coupling are measured with a 1-port technique. Simulation in ADS is then used
to establish a more accurate coupling coefficient range (147). The range of k1,3 is 0.0049
to 0.0064.
The optimal power transfer condition is different for every unique coupling
coefficient. For a first generation technology, the goal of the powering system is to
provide sufficient powering and not always optimal powering under every condition. The
power required by a device described in chapter 2 is typically < 4 mW. Assuming a 60%
rectifier efficiency, 6.67 mW of power delivered to the load is the targeted specification.
Source power is designed for 500 mW, although higher levels can be used. The minimum
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power transfer efficiency specification at a singular frequency for all coupling
configurations is 1.33%.
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Figure 4.14 Coupling trends throughout the three axis cage. k13 is the coupling
coefficient between the transmit and receive coils. a) Coupling in the XZ plane at Y = 0
cm. The receive coil is moved along the dotted lines in the Z direction. Colors of the
dotted line in the schematic correspond to the colors in the plot. Coupling is greatest near
the coil wrappings (0, 13, 26 cm). The coupling dips between the wrappings (6.5, 19.5
cm). These dips are the weakest coupling points when the receive coil is parallel to the
transmit coil. The same trend is observed in the YZ plane. b) Coupling in the XY plane at
Z = 26 cm. The receive coil is moved along the dotted lines in the X direction. The
greatest coupling occurs at the ends (0 and 26 cm). The coupling dips toward the middle.
The same trend is observed while moving the XY plane along the Z-axis. c) Coupling as
a function of angle. As the receive coil is turned from parallel to perpendicular, the
coupling drops. At 90o, the coupling is negligible.
The parameters used for optimization are shown in Table 4.5. The targeted critical
coupling point between the receive and transmit coil is 0.005, which is near the coupling
coefficient of most cage areas away from the edges. The implemented capacitor values
were verified by measurement on the VNA.

Table 4.5 3-Axis RCFET Wireless Powering Cage Optimization Parameters
RCFET Input values
L1
4252 nH
L2a
4400 nH
L2b
4325 nH
L3
346.9 nH
Q1
323.8
Q2a
262.5
Q2b
270.1
Q3
85
f0
FBW
Rs
ZL
k12a
k13 (target)
k2a,3

4.0 MHz
0.043
50 Ω
50 Ω
0.0047
0.005
0.001

Calculated values
Cs1
399.12 pF
Cp1
5430.31 pF
Cs2
6303.30 pF
Cp2
16497.64 pF

Implemented values measured
by VNA @ 4 MHz
Cs1
399.6 pF
Cp1
5.413 nF
Cs2
6.272 nF
Cp2
16.972 nF
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The physical realization of the cage is shown in Figure 4.15. Receive coils and power
measurement systems for a 50 Ω load and complex load are pictured in Figure 4.15c. The
coil on the left of is matched for a 50 Ω load. The devices in the middle and on the right
of Figure 4.15c are wireless power measurement boards used when transitioning to a non50 Ω. Using a 2-port setup on the VNA, the power transfer measurements are made by
connecting the K0,1 input to port 1 and K3,4 output to port 2. The power transfer
simulation and measurements for a 50 Ω load are shown in Figure 4.16.

Figure 4.15 The three axis RCFET powering system. a) side angled view of cage. The
external K inverter, K01, is boxed in blue. Three perpendicular coils are seen. Each side of
the bottom of the cage is 12 inches. The height is 11.5 inches. b) Side view of cage. The
arrow points to coil 1. Coil 2 wraps vertically and perpendicular to coil 1. c) Receive
coils and powering boards. Coil 3, the receive coil, is shown by the red arrows. K3,4 for a
50 ohm load is boxed in blue. The devices on the left are unpackaged (middle) and
packaged (right) versions of the wireless power measurement system. The AC voltage is
rectified to DC and then measured with a MCU. The data is then wirelessly transmitted to
a basestation. Sampling occurs at 2.5 kHz. The black bar is 5 mm.

Figure 4.16 displays power transfer in terms of S21. Measurements at a strong and weak
coupling points corresponding to the general trends in Figure 4.14 are made. Additionally,
a measurement is taken at the middle of the cage. All measurements are taken with the
receive coil parallel to the transmit or relay coil.
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Figure 4.16 Two port measurements of the powering cage for a 50 Ω load. All
measurements are taken with the receive coil parallel to the relay or transmit coil. a)
Measurement taken with coupling at a maximum to the transmit coil (corner location, see
Figure 5.14). Dotted line is the simulation case and red line is the measurement. b) Same
as (a), but coupled to the relay coil. c) Measurement comparisons of the a strong coupling
position (red), the middle of the cage (blue) and a weak coupling position (black) when
coupled to the transmit coil. d) Same as (c), but coupled to the relay coil.

Figure 4.16a and Figure 4.16b show simulation (dotted black trace) S21 response and the
measured S21 response (solid red trace) for the receive coil coupling to the transmit and
relay coils, respectively. These measurements were made at the optimal coupling location
(corner position next to a coil turn). Interestingly, the power transfer is greater across the
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measured frequencies, but at 4 MHz, there is a negligible difference. In Figure 4.16c and
Figure 4.16d, the coupling at a strong coupling location (red trace), the center of the cage
(blue), and a weak coupling location (black trace) are shown for the receive coil coupling
to the transmit a relay coil respectively. The maximum PTE of the measurements for a 50
Ω load range from 2.3 to 7%.

4.5.3

Preliminary in vivo Validation

Validating the cage with a device requires retuning the system for a complex load.
A power management circuit is used to convert AC to DC, store energy, and regulate
supply voltages (Figure 4.15c). A two-stage rectifier topology is used to perform AC to
DC conversion and a low noise linear dropout regulator provides a 1.8 V supply voltage.
The setup is similar to Figure 2.25, but there is only one device and an additional 700 Ω
load at the regulator output. From previous design experience with a 1-axis cage and
ADS simulation, the rectifier board impedance is known to be 0.78 + j106.9 Ω. Using
RCFET simulations for the known rectifier load, the characteristic impedances K-inverter
capacitor values are determined and mounted onto the power measurement boards. With
a 500 mW input at 4.01 MHz, rectified voltage values range from 1.79- 3.32 V.
Assuming 50% rectifier efficiency, this translates into a PTE range of 1.8-6.28% which is
in good agreement with the 50 Ω load case.
Preliminary in vivo validation is performed in two similar cages and brief
recording sessions. Future work will be to pursue validation with longer time periods.
The packaged device in Figure 4.15c is implanted subcutaneously in the flank of a rat,
and the rat is allowed to roam freely in the cage. The cage switches are operated in an
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open-loop configuration and constantly toggled at 200 Hz (Table 4.3). The rectified
voltage is reported and shown in Figure 4.17. The rat is visually observed and time points
where the rat is moving or is stationary are indicated in red and blue, respectively. As the
rat moves, it can be seen that the voltage fluctuates. Critically, the rectified voltage is
maintained above the regulator voltage of 1.8V. When the animal is stationary, the
rectified voltage can be seen to stable. At the beginning and end of the recording session
shown, the animal is in different locations of the cage explaining the difference in
rectified voltage.

Figure 4.17 Wireless powering in an animal using the three axis RCFET cage. Rectified
voltage at the input of the regulator is shown and continuously stays above 1.8 V
(regulator voltage). Rectified voltage fluctuates more while the animal is moving than
when it is stationary. Power output is 630 mW at 4.11 MHz.
The second data set uses the same device configuration as Figure 2.25. One rectifier
board supplies power to two devices for 4 channels of biopotential acquisition. In this
cage setup, the optical relay switches are operated in a closed-loop manner. A simple
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control algorithm is implemented into the basestation. The basestation both receives data
from the devices and toggles the relay coils. The basestation uses a timer that looks for
data packets received. If a data packet is not received for 200 ms, indicating a lack of
power, then the switching function is initiated. This is preferable to the open-loop case
since the open loop switching frequency is in input range of acquisition devices. Noise
from switching will be introduced and amplified. More complex control algorithms can
be designed for smoother voltage regulation and less packet loss. The recording session is
for 4.5 minutes, and the data of interest is the number of data points received. 673770
data points are expected in this time frame and 636940 data points were received
indicating a 94.53% of successful data transmission. Additionally, the data suggests that
the implanted devices did not restart and the lost packets were due to dropped packets
and not powering. This data shows the three-axis RCFET powering cage can reliably
deliver power to multiple devices with less than 1 W output power. Further in vivo
validation with biopotential measurements is required.

4.6

Conclusion

The design methodology and bench top characterization of a three-axis RCFET cage
is presented. For a 20 mm diameter receive coil, PTE from 1.8 – 6.28% are achieved. The
powering volume is 11 in x 11 in x 11 in and is large enough to house adult rats.
Preliminary in vivo results are shown, but further chronic work is needed to establish the
suitability of the cage for chronic epilepsy and SUDEP experiments.
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CHAPTER 5. CONCLUSION

Implantable medical devices are becoming more prominent, and DBS is entering an era
of tremendous clinical investigation. Optimization of DBS to control diseases and
disorders such as epilepsy, SUDEP, and urinary incontinence will require much
laboratory research. Miniature wireless devices are thus poised to greatly enable
neuroscience researchers. This dissertation presented a platform of wireless technologies
that can be used for biopotential acquisition, electrical stimulation, optical stimulation in
optogenetics, and freely behaving wireless powering. To the author’s knowledge, Chapter
2 presents the first implantable, miniature closed-loop device for use in chronic epilepsy
experiments. Measuring 7 x 14 x 3mm and weighing less than 0.7 g, it is a uniquely small
COTS device that can be easily integrated with a wireless powering system and remain
implantable. The core recording and stimulating technologies were validated in vivo, and
it was shown that the device could acquire ECG, respiratory EMG, ECoG, LFP, and
bladder pressure reliably. Additionally, the subsystems can be integrated with different
combinations to arrive at the desired functionality. For instance, two devices with two
channels of biopotential acquisition were connected to a single powering system and
simultaneously acquired 4 channels of biopotentials. Chapter 3 presented a miniature,
fiber-coupled, deep brain optical stimulator for use in optogenetics. This was one of the
earliest demonstrations of wireless deep brain optical stimulation in freely behaving
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animals. The device offers programmable stimulation parameters and consumes less than
23 µW during deep sleep operation. The MCU controls the stimulation parameters and as
such, the optical module can be integrated with the technologies in Chapter 2 for closedloop optical stimulation. The device weighs less than 2 g and demonstrated dosedependent conditioned place preference (CPP) in transgenic mice. Chapter 4 presented
the design and characterization of a three-axis RCFET wireless powering cage. This
WPT system is unique in that it offers a volume (11 x 11 x11 in3) of wireless power that
can support housing of adult rats. PTE of 1.8-6.28% is achieved, and this can support
power for 1 to 2 devices presented in chapter 3. Typically, only 1 W of power is needed
and this is below comparable power transfer systems. Further in vivo validation is
required, but preliminary results are promising. This work is novel in the breadth of
technologies presented. Typically, focus is in optimizing a subsystem to achieve
particular specifications. In this work, full system design, characterization and integration
are demonstrated. To further advance this platform, future work should focus on
increased channel counts for acquisition and modulation, integration of all of device
technologies into a singular form factor, designing modular powering cages for large
behavioral arenas and housing units, and further miniaturization of all implantable
technologies.
A foundational premise of engineering is to use physics and technology to better
the lives of individuals and societies. This work hopes to contribute to the betterment of
the quality of lives of individuals affected by epilepsy, SUDEP, and urinary incontinence.
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Research Interest
Epilepsy affects 1% of the world’s population and one-third of the patients are refractory to
current anti-epileptic drugs. Electrical neuromodulation techniques—vagus nerve stimulation
(VNS) and deep brain stimulation (DBS)—offer invasive, but promising paradigms to decrease
seizure rates. In particular, closed-loop, responsive DBS at critical brain pathways can be an
effective method to abolish seizures milliseconds after detection; however, the algorithms,
electrode placement, and stimulation waveforms must be optimized to target specific populations
of neurons. Optogenetics offers increasing spatial and molecular resolution to modulate and
discover brain microcircuits by delivering opsins that are sensitive to specific wavelengths of
light to selective neurons. The promise of optogenetics could be realized by “turning off” large
populations of diseased neurons with optical stimulation shortly after detecting a seizure. While
engineering of devices can improve their efficacies, the agglomeration of neurobiology, disease
pathology, and physiological mechanisms of electrical and optical stimulation should drive the
new generation of implantable devices. My interests lie in this vast and largely unexplored
horizon. Specifically, I am interested in full system architectures of devices, low power control
algorithms, and pairing traditional transistor based tools with molecular tools. Additionally, I am
interested in cost-effective design solutions for resource poor populations.
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Skill sets
• Altium Designer—printed circuit board design and testing
• Matlab programming
• Labview programming
• Embedded systems – firmware programming
• Bandpass filter radiofrequency powering
• Rodent surgery
• Electrical stimulation paradigms
• Optical stimulation paradigms
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Research Experience
Center for Implantable Devices, Major advisor: Professor Pedro Irazoqui
Weldon School of Biomedical Engineering
Purdue University, West Lafayette, IN
•
•
•
•

July 2010-May
2015
Designed an implantable, wireless closed-loop electrical DBS research device
Designed a skull mounted, deep brain optical stimulator for use in optogenetics
Designed an omnidirectional RF wireless powering system for implantable devices
Validated all designs in vivo

Department of Pharmacology, Professor John Jefferys’ Lab
University of Oxford, Oxford, England
Visiting Researcher
•
•

Implanted devices designed at Purdue to study SUDEP
Performed acute study to identify DBS brain targets in epilepsy model

The Jackson Laboratory, Dr. Simon John’s Lab
Bar Harbor, Maine
Visiting Researcher
•
•

June 2014-Nov,
2014

June 2012-Dec,
2012

Performed chronic optical DBS study in transgenic mice
Demonstrated optical dose-dependent conditioning in mice with wireless device

Weldon School of Biomedical Engineering
Purdue University, West Lafayette, IN
Summer 2009
MSTP rotation with Dr. Chang Lu
• Investigated oil compounds to optimize the separation of cell culture medium into single
droplets in a soft-lithography microfluidic device
• The device was intended to separate single cells into single droplets for techniques such as
single cell electroporation
Weldon School of Biomedical Engineering
Purdue University, West Lafayette, IN
Summer 2008
MSTP rotation with Dr. Mark Lawley
• Investigated scheduling algorithms to optimize the amount of extra clinic hours doctors
should provide to maximize profits and minimize loss of revenue due to patient no-shows
Biomedical Engineering Summer Internship Program
National Institutes of Health
Summer 2007
• 1 of 16 biomedical engineering students selected from the nation
• Used tandem mass spectrometers to identify and quantify the movement of proteins in
response to vasopressin in rat renal cells
• Developed signal processing quality control of elution profiles developed from coupled
high performance liquid chromatography and mass spectrometry
Indiana University School of Medicine, Indianapolis, IN
Summer 2006
Research Intern in the Wells Center – Dr. Wade Clapp Laboratory
• Conducted several experiments in vitro to determine effects of
multi-tyrosine receptor kinase inhibitor, Sutent, on Nf1+/- murine-mast cell function
• Cultured murine mast cells and fibroblasts
• Presented findings to fellow interns, medical students, physicians, and physician scientists
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Weldon School of Biomedical Engineering
Purdue University, West Lafayette, IN
Dr. Eric Nauman Lab – Undergraduate researcher
•
•
•
•

Jan 2005 – May
2007

Investigated dielectric properties of adult bone marrow stem cells in vitro
Wrote LabVIEW program for solenoid fixture
Modeled applied direct currents and magnetic fields to cell culturing device
Designed iron core Helmholtz solenoid fixture with flexibility to culture cells

Work Experience
Stryker Instruments, Kalamazoo, MI
Test Lab Summer Coop
• Performed over 20 tests
• Redesigned, built, and evaluated a specialized test fixture
• Designed a test fixture to assist measurements of tensile force
• Received excellent evaluation
Leadership Activities
Biomedical Engineering Graduate Student Association (BMEGSA)

Summer 2005

May 2011May2014

Big 10 BME Graduate Student Speaker Exchange Program Coordinator
• Spearheaded the speaker exchange program between Big 10 universities
Engineering World Health (EWH) – Purdue Chapter

August 2006 –
May 2008

President
• Lead a group of students to establish the Purdue Chapter
• Organized interior and exterior renovations at the Trinity Nursing Center for Infant Health
• Received $1500 grant from the Office of Engagement to develop an education center for
the Trinity Nursing Center for Infant Health
• Developed and led a Sunday mentoring program in which college students worked with
elementary students to learn about engineering
International Experiences
Attended the Confucius Institute of Indianapolis Summer Camp
Guangzhou, China
May 2009
• Attended Sun Yat-set University (SYSU) for language courses and participated in the
medical program to experience traditional Chinese medicine and the Chinese health care
system
Attended Pop-Wuj Language School in Xela, Guatemala
May 2008
• Attended daily Spanish training sessions for several hours per day
• Worked in their low-cost medical clinic weekly
• Attended medical mission trips to sparse Mayan communities
• Assisted in building brick stoves external to the homes for Mayan communities
Attended China Maymester 2007, “Introduction to Intercultural Teamwork”
May 2007
• Traveled to Shanghai, Ningbo, Beijing, and Harbin and interacted with Chinese
undergraduate students. We also explored cultural differences and how partnerships
between our countries would work.
Service and Outreach Activities
Biomedical Engineering Graduate Student Association

July 2010-May
2015
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•
•

Volunteered at outreach activities at middle schools
Purdue Spring Fest volunteer to discuss biomedical engineering to the public

Indiana University Student Outreach Clinic, Indianapolis, IN—medical-student run clinic for the
underserved
Jan 2009 – May
2010
• Volunteered every few weeks. Performed triage, patient medical and social histories, and
patient physical exam
• Wrote protocols to assist patients in navigating the medical system in Indianapolis
Music Program at Riley’s Children Hospital, Indianapolis, IN
•
•
•

Jan 2009 – May
2010
Formed a violin trio and a violin-guitar duet to perform music every week in the atrium
Performed the “Day of Music” celebration over the 2009 winter holiday as the H1N1
emergency restricted outside musicians from visiting Riley Hospital
Requested to perform for the Great Lake Region of the American Music Therapy
Association in March, 2010

Timmy Foundation – Purdue Chapter
•
•
•

•

Aug 2006 – May
2008

Ecuador Mission Trip - served 1000 people in need over Spring Break
Worked primarily in the pharmacy and triage
Assisted in fundraising and donation collection events for Ecuador
Served as Director of Community Engagement

Honors/Awards/Fellowships
Fearnot-Laufman-Greatbatch Award
University Fellowship—Indiana University-Purdue University Indianapolis
• 1-year graduate fellowship that funded tuition, stipend,
and an $800 travel allowance
GA Ross Award – Outstanding Graduating Man at Purdue University
Phi Beta Kappa Honor Society
Tau Beta Pi – Engineering Honor Society
Phi Kappa Phi Honor Society

2012
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2008
2008
2007

PUBLICATIONS

158

PUBLICATIONS

1. Lee ST, Williams PA, Braine CE, Lin DT, John SWM, and Irazoqui, PP. A miniature,
fiber-coupled, wireless, deep-brain optogenetic stimulator. Trans. Neur. Sys. Rehab.
Engineering. (in press).
2. Nagaraj V, Lee ST, Krook-Magnuson E, Soltesz I, Benquet P, Irazoqui PP, Netoff T.
"Future of Seizure Prediction and Intervention: Closing the loop." Journal of Clinical
Neurophysiology. (in press)
3. Lee ST*, Bercich RA*, Pederson D, Wang Z, Mei H, Qing K, Albors GA, Zhang H,
Irazoqui PP. “The Bionode: an Implantable Closed-Loop Research Platform.” 2015.
Manuscript in preparation.
4. Lee ST*, Mei H, Irazoqui PP. “A Three-Axis Wireless Power Transfer System for
Chronic Experiments.” 2015. Manuscript in preparation.

